0000891532 false FY PERMA FIX ENVIRONMENTAL SERVICES INC P10Y P3Y http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet P6M http://fasb.org/us-gaap/2022#AccruedCappingClosurePostClosureAndEnvironmentalCosts http://fasb.org/us-gaap/2022#AccruedCappingClosurePostClosureAndEnvironmentalCostsNoncurrent 0000891532 2022-01-01 2022-12-31 0000891532 2022-06-30 0000891532 2023-02-14 0000891532 2022-12-31 0000891532 2021-12-31 0000891532 2021-01-01 2021-12-31 0000891532 us-gaap:CommonStockMember 2020-12-31 0000891532 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000891532 PESI:CommonStockHeldInTreasuryMember 2020-12-31 0000891532 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000891532 PESI:NoncontrollingInterestInSubsidiaryMember 2020-12-31 0000891532 us-gaap:RetainedEarningsMember 2020-12-31 0000891532 2020-12-31 0000891532 us-gaap:CommonStockMember 2021-12-31 0000891532 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000891532 PESI:CommonStockHeldInTreasuryMember 2021-12-31 0000891532 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000891532 PESI:NoncontrollingInterestInSubsidiaryMember 2021-12-31 0000891532 us-gaap:RetainedEarningsMember 2021-12-31 0000891532 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000891532 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0000891532 PESI:CommonStockHeldInTreasuryMember 2021-01-01 2021-12-31 0000891532 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0000891532 PESI:NoncontrollingInterestInSubsidiaryMember 2021-01-01 2021-12-31 0000891532 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0000891532 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000891532 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000891532 PESI:CommonStockHeldInTreasuryMember 2022-01-01 2022-12-31 0000891532 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0000891532 PESI:NoncontrollingInterestInSubsidiaryMember 2022-01-01 2022-12-31 0000891532 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000891532 us-gaap:CommonStockMember 2022-12-31 0000891532 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000891532 PESI:CommonStockHeldInTreasuryMember 2022-12-31 0000891532 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000891532 PESI:NoncontrollingInterestInSubsidiaryMember 2022-12-31 0000891532 us-gaap:RetainedEarningsMember 2022-12-31 0000891532 PESI:PermaFixERRGMember 2022-12-31 0000891532 PESI:EngineeringRemediationResourcesGroupIncMember 2022-12-31 0000891532 PESI:PFMPolandMember 2021-10-01 2021-12-31 0000891532 us-gaap:BuildingMember srt:MinimumMember 2022-01-01 2022-12-31 0000891532 us-gaap:BuildingMember srt:MaximumMember 2022-01-01 2022-12-31 0000891532 PESI:OfficeFurnitureAndEquipmentMember srt:MinimumMember 2022-01-01 2022-12-31 0000891532 PESI:OfficeFurnitureAndEquipmentMember srt:MaximumMember 2022-01-01 2022-12-31 0000891532 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember PESI:GovernmentClientsMember 2022-01-01 2022-12-31 0000891532 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember PESI:GovernmentClientsMember 2021-01-01 2021-12-31 0000891532 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember PESI:CustomerOneMember 2022-01-01 2022-12-31 0000891532 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember PESI:CustomerTwoMember 2022-01-01 2022-12-31 0000891532 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember PESI:CustomerOneMember 2021-01-01 2021-12-31 0000891532 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember PESI:CustomerTwoMember 2021-01-01 2021-12-31 0000891532 PESI:ReceiptMember srt:MinimumMember 2022-12-31 0000891532 PESI:ReceiptMember srt:MaximumMember 2022-12-31 0000891532 PESI:TreatmentOrProcessingMember srt:MinimumMember 2022-12-31 0000891532 PESI:TreatmentOrProcessingMember srt:MaximumMember 2022-12-31 0000891532 PESI:ShipmentOrFinalDisposalMember srt:MinimumMember 2022-12-31 0000891532 PESI:ShipmentOrFinalDisposalMember srt:MaximumMember 2022-12-31 0000891532 PESI:TreatmentMember PESI:FixedPriceMember 2022-01-01 2022-12-31 0000891532 PESI:ServicesMember PESI:FixedPriceMember 2022-01-01 2022-12-31 0000891532 PESI:FixedPriceMember 2022-01-01 2022-12-31 0000891532 PESI:TreatmentMember PESI:FixedPriceMember 2021-01-01 2021-12-31 0000891532 PESI:ServicesMember PESI:FixedPriceMember 2021-01-01 2021-12-31 0000891532 PESI:FixedPriceMember 2021-01-01 2021-12-31 0000891532 PESI:TreatmentMember PESI:TimeandMaterialsMember 2022-01-01 2022-12-31 0000891532 PESI:ServicesMember PESI:TimeandMaterialsMember 2022-01-01 2022-12-31 0000891532 PESI:TimeandMaterialsMember 2022-01-01 2022-12-31 0000891532 PESI:TreatmentMember PESI:TimeandMaterialsMember 2021-01-01 2021-12-31 0000891532 PESI:ServicesMember PESI:TimeandMaterialsMember 2021-01-01 2021-12-31 0000891532 PESI:TimeandMaterialsMember 2021-01-01 2021-12-31 0000891532 PESI:TreatmentMember 2022-01-01 2022-12-31 0000891532 PESI:ServicesMember 2022-01-01 2022-12-31 0000891532 PESI:TreatmentMember 2021-01-01 2021-12-31 0000891532 PESI:ServicesMember 2021-01-01 2021-12-31 0000891532 PESI:TreatmentMember PESI:DomesticGovernmentMember 2022-01-01 2022-12-31 0000891532 PESI:ServicesMember PESI:DomesticGovernmentMember 2022-01-01 2022-12-31 0000891532 PESI:DomesticGovernmentMember 2022-01-01 2022-12-31 0000891532 PESI:TreatmentMember PESI:DomesticGovernmentMember 2021-01-01 2021-12-31 0000891532 PESI:ServicesMember PESI:DomesticGovernmentMember 2021-01-01 2021-12-31 0000891532 PESI:DomesticGovernmentMember 2021-01-01 2021-12-31 0000891532 PESI:TreatmentMember PESI:DomesticCommercialMember 2022-01-01 2022-12-31 0000891532 PESI:ServicesMember PESI:DomesticCommercialMember 2022-01-01 2022-12-31 0000891532 PESI:DomesticCommercialMember 2022-01-01 2022-12-31 0000891532 PESI:TreatmentMember PESI:DomesticCommercialMember 2021-01-01 2021-12-31 0000891532 PESI:ServicesMember PESI:DomesticCommercialMember 2021-01-01 2021-12-31 0000891532 PESI:DomesticCommercialMember 2021-01-01 2021-12-31 0000891532 PESI:TreatmentMember PESI:ForeignGovernmentMember 2022-01-01 2022-12-31 0000891532 PESI:ServicesMember PESI:ForeignGovernmentMember 2022-01-01 2022-12-31 0000891532 PESI:ForeignGovernmentMember 2022-01-01 2022-12-31 0000891532 PESI:TreatmentMember PESI:ForeignGovernmentMember 2021-01-01 2021-12-31 0000891532 PESI:ServicesMember PESI:ForeignGovernmentMember 2021-01-01 2021-12-31 0000891532 PESI:ForeignGovernmentMember 2021-01-01 2021-12-31 0000891532 PESI:TreatmentMember PESI:ForeignCommercialMember 2022-01-01 2022-12-31 0000891532 PESI:ServicesMember PESI:ForeignCommercialMember 2022-01-01 2022-12-31 0000891532 PESI:ForeignCommercialMember 2022-01-01 2022-12-31 0000891532 PESI:TreatmentMember PESI:ForeignCommercialMember 2021-01-01 2021-12-31 0000891532 PESI:ServicesMember PESI:ForeignCommercialMember 2021-01-01 2021-12-31 0000891532 PESI:ForeignCommercialMember 2021-01-01 2021-12-31 0000891532 PESI:YearToDateChangesMember 2022-01-01 2022-12-31 0000891532 us-gaap:PatentsMember 2022-01-01 2022-12-31 0000891532 us-gaap:PatentsMember 2022-12-31 0000891532 us-gaap:PatentsMember 2021-12-31 0000891532 PESI:SoftwareMember 2022-01-01 2022-12-31 0000891532 PESI:SoftwareMember 2022-12-31 0000891532 PESI:SoftwareMember 2021-12-31 0000891532 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-12-31 0000891532 us-gaap:CustomerRelationshipsMember 2022-12-31 0000891532 us-gaap:CustomerRelationshipsMember 2021-12-31 0000891532 PESI:TwoThousandThreeStockPlanMember 2021-07-20 0000891532 PESI:TwoThousandThreeStockPlanMember srt:DirectorMember srt:MinimumMember PESI:ElectionMember 2021-07-20 0000891532 srt:DirectorMember srt:MaximumMember PESI:TwoThousandThreeStockPlanMember PESI:ElectionMember 2021-07-20 0000891532 srt:DirectorMember srt:MinimumMember PESI:TwoThousandThreeStockPlanMember PESI:ReelectionMember 2021-07-20 0000891532 srt:DirectorMember srt:MaximumMember PESI:TwoThousandThreeStockPlanMember PESI:ReelectionMember 2021-07-20 0000891532 PESI:TwoThousandThreeStockPlanMember 2021-07-18 2021-07-20 0000891532 PESI:TwoThousandThreeOutsideDirectorsStockPlanMember 2022-01-01 2022-12-31 0000891532 us-gaap:CommonStockMember PESI:TwoThousandThreeOutsideDirectorsStockPlanMember 2022-12-31 0000891532 PESI:TwoThousandThreeOutsideDirectorsStockPlanMember 2022-12-31 0000891532 PESI:TwoThousandAndSeventeenStockOptionPlanMember PESI:OfficersAndEmployeesMember 2022-12-31 0000891532 PESI:TwoThousandAndSeventeenStockOptionPlanMember 2022-01-01 2022-12-31 0000891532 PESI:TwoThousandAndSeventeenStockOptionPlanMember 2022-12-31 0000891532 PESI:TwoThousandAndThreeStockOptionPlanMember PESI:DrLouisCentofantiMember 2022-07-20 2022-07-21 0000891532 PESI:TwoThousandSeventeenStockOptionPlanMember 2022-07-20 2022-07-21 0000891532 PESI:TwoThousandSeventeenStockPlanMember srt:MaximumMember 2021-10-13 2021-10-14 0000891532 srt:ChiefExecutiveOfficerMember PESI:IncentiveStockOptionAgreementMember PESI:TwoThousandSeventeenStockPlanMember 2021-10-12 2021-10-14 0000891532 srt:ChiefFinancialOfficerMember PESI:IncentiveStockOptionAgreementMember PESI:TwoThousandSeventeenStockPlanMember 2021-10-12 2021-10-14 0000891532 PESI:EVPOfStrategicInitiativesMember PESI:IncentiveStockOptionAgreementMember PESI:TwoThousandSeventeenStockPlanMember 2021-10-12 2021-10-14 0000891532 PESI:EVPofWasteTreatmentOperationsMember PESI:IncentiveStockOptionAgreementMember PESI:TwoThousandSeventeenStockPlanMember 2021-10-12 2021-10-14 0000891532 PESI:EVPofNuclearandTechnicalServicesMember PESI:IncentiveStockOptionAgreementMember PESI:TwoThousandSeventeenStockPlanMember 2021-10-12 2021-10-14 0000891532 PESI:TwoThousandSeventeenStockPlanMember PESI:IncentiveStockOptionAgreementMember 2021-10-12 2021-10-14 0000891532 PESI:TwoThousandAndThreePlanMember PESI:NonQualifiedStockOptionsMember 2021-07-18 2021-07-20 0000891532 PESI:TwoThousandAndThreePlanMember PESI:NonQualifiedStockOptionsMember 2021-05-02 2021-05-04 0000891532 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000891532 us-gaap:EmployeeStockOptionMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000891532 us-gaap:EmployeeStockOptionMember us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000891532 PESI:EmployeeAndDirectorsMember 2022-12-31 0000891532 PESI:EmployeeAndDirectorsMember 2022-01-01 2022-12-31 0000891532 PESI:TwoThousandAndSeventeenStockOptionPlanMember PESI:ConsultantMember 2017-07-26 2017-07-27 0000891532 PESI:RobertFergusonMember 2018-05-01 2018-05-31 0000891532 PESI:FergusonStockOptionMember PESI:SecondMilestoneMember 2017-07-26 2017-07-27 0000891532 PESI:FergusonStockOptionMember PESI:ThirdMilestoneMember 2017-07-26 2017-07-27 0000891532 PESI:RobertFergusonMember 2022-12-29 2022-12-31 0000891532 PESI:RobertFergusonMember 2022-12-31 0000891532 PESI:RobertFergusonMember 2019-04-02 0000891532 PESI:RobertFergusonMember 2019-03-30 2019-04-02 0000891532 PESI:TwoThousandThreeOutsideDirectorsStockOptionPlanMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000891532 PESI:TwoThousandThreeOutsideDirectorsStockOptionPlanMember us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000891532 PESI:TwoThousandThreeOutsideDirectorsStockOptionPlanMember 2022-01-01 2022-12-31 0000891532 PESI:PortionOfDirectorFeeEarnedInCommonStockMember PESI:The2003OutsideDirectorsStockPlanMember 2022-01-01 2022-12-31 0000891532 PESI:PortionOfDirectorFeeEarnedInCommonStockMember PESI:The2003OutsideDirectorsStockPlanMember 2021-01-01 2021-12-31 0000891532 PESI:SubscriptionAgreementsMember 2021-09-28 2021-09-30 0000891532 PESI:EmployeeStockOptionsGrantedMember 2022-12-31 0000891532 PESI:EmployeeStockOptionsGrantedMember 2021-12-31 0000891532 PESI:EmployeeStockOptionsGrantedMember 2022-01-01 2022-12-31 0000891532 PESI:EmployeeStockOptionsGrantedMember 2021-01-01 2021-12-31 0000891532 PESI:OutsideDirectorStockOptionsGrantedMember 2022-12-31 0000891532 PESI:OutsideDirectorStockOptionsGrantedMember 2021-12-31 0000891532 PESI:OutsideDirectorStockOptionsGrantedMember 2022-01-01 2022-12-31 0000891532 PESI:OutsideDirectorStockOptionsGrantedMember srt:MinimumMember 2021-01-01 2021-12-31 0000891532 PESI:OutsideDirectorStockOptionsGrantedMember srt:MaximumMember 2021-01-01 2021-12-31 0000891532 PESI:OutsideDirectorStockOptionsGrantedMember 2021-01-01 2021-12-31 0000891532 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0000891532 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0000891532 PESI:DirectorStockOptionsMember 2022-01-01 2022-12-31 0000891532 PESI:DirectorStockOptionsMember 2021-01-01 2021-12-31 0000891532 us-gaap:StockOptionMember 2021-12-31 0000891532 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0000891532 us-gaap:StockOptionMember 2022-12-31 0000891532 us-gaap:StockOptionMember 2020-12-31 0000891532 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0000891532 PESI:StockOptionOutstandingMember 2022-01-01 2022-12-31 0000891532 PESI:SubscriptionAgreementsMember 2021-09-30 0000891532 PESI:PlacementAgencyAgreementMember PESI:WellingtonShieldsandCoMember 2021-09-22 2021-09-23 0000891532 PESI:PlacementAgencyAgreementMember PESI:WellingtonShieldsandCoMember 2022-01-01 2022-12-31 0000891532 PESI:PFDMember 2022-12-31 0000891532 PESI:PFMMember 2022-12-31 0000891532 PESI:PFSGMember 2022-12-31 0000891532 PESI:RevolvingCreditMember 2022-12-31 0000891532 PESI:RevolvingCreditMember 2021-12-31 0000891532 PESI:TermLoanMember 2022-12-31 0000891532 PESI:TermLoanMember 2021-12-31 0000891532 PESI:CaptailLineMember 2022-12-31 0000891532 PESI:CaptailLineMember 2021-12-31 0000891532 PESI:NotePayableMember 2022-12-31 0000891532 PESI:NotePayableMember 2021-12-31 0000891532 PESI:RevolvingCreditMember 2020-05-07 2020-05-08 0000891532 PESI:RevolvingCreditMember 2022-12-31 0000891532 PESI:RevolvingCreditMember 2021-12-31 0000891532 PESI:TermLoanMember 2020-05-07 2020-05-08 0000891532 PESI:TermLoanMember 2022-12-31 0000891532 PESI:TermLoanMember 2021-12-31 0000891532 PESI:CapitalLineMember 2021-05-03 2021-05-04 0000891532 PESI:CapitalLineMember 2022-12-31 0000891532 PESI:NotePayableMember 2022-12-31 0000891532 PESI:NotePayableMember 2021-12-31 0000891532 us-gaap:RevolvingCreditFacilityMember PESI:LoanAgreementMember PESI:PNCBankMember 2020-05-06 2020-05-08 0000891532 us-gaap:RevolvingCreditFacilityMember PESI:LoanAgreementMember PESI:PNCBankMember 2020-05-08 0000891532 us-gaap:RevolvingCreditFacilityMember PESI:PNCBankMember PESI:LoanAgreementMember us-gaap:SubsequentEventMember 2023-03-21 0000891532 PESI:LoanAgreementMember PESI:PNCBankMember PESI:TermLoanMember us-gaap:SubsequentEventMember 2023-03-21 0000891532 PESI:TermLoanMember PESI:PNCBankMember PESI:LoanAgreementMember us-gaap:SubsequentEventMember 2023-03-20 2023-03-21 0000891532 2021-05-04 0000891532 PESI:CaptailLineMember PESI:PNCBankMember 2022-12-31 0000891532 PESI:CaptailLineMember PESI:PNCBankMember 2022-01-01 2022-12-31 0000891532 PESI:AmendedLoanAgreementMember PESI:LenderMember 2022-01-01 2022-12-31 0000891532 us-gaap:RevolvingCreditFacilityMember PESI:LenderMember 2022-12-31 0000891532 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember PESI:LenderMember 2022-01-01 2022-12-31 0000891532 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember PESI:LenderMember 2022-01-01 2022-12-31 0000891532 us-gaap:RevolvingCreditFacilityMember PESI:LenderMember 2022-01-01 2022-12-31 0000891532 PESI:RevisedLoanAgreementMember PESI:PNCBankMember 2022-12-31 0000891532 us-gaap:RevolvingCreditFacilityMember 2022-12-31 0000891532 2021-07-01 2021-09-30 0000891532 us-gaap:OtherNonoperatingIncomeExpenseMember 2021-07-01 2021-09-30 0000891532 PESI:PaycheckProtectionProgramLoanMember PESI:LenderMember 2020-04-30 0000891532 PESI:PaycheckProtectionProgramLoanMember PESI:LenderMember 2020-04-01 2020-04-30 0000891532 PESI:PaycheckProtectionProgramLoanMember PESI:LenderMember 2021-06-14 2021-06-15 0000891532 PESI:PaycheckProtectionProgramLoanMember PESI:LenderMember 2021-01-01 2021-12-31 0000891532 PESI:DeferralofEmploymentTaxDepositsMember PESI:DecemberThirtyOneTwoThousandAndTwentyOneMember 2020-03-27 2020-12-31 0000891532 PESI:DeferralofEmploymentTaxDepositsMember PESI:DecemberThirtyOneTwoThousandAndTwentyTwoMember 2020-03-27 2020-12-31 0000891532 PESI:DeferralofEmploymentTaxDepositsMember 2021-12-31 0000891532 2021-12-01 2021-12-31 0000891532 2022-12-01 2022-12-31 0000891532 country:US 2022-01-01 2022-12-31 0000891532 country:US 2021-01-01 2021-12-31 0000891532 country:CA 2022-01-01 2022-12-31 0000891532 country:CA 2021-01-01 2021-12-31 0000891532 country:GB 2022-01-01 2022-12-31 0000891532 country:GB 2021-01-01 2021-12-31 0000891532 country:PL 2022-01-01 2022-12-31 0000891532 country:PL 2021-01-01 2021-12-31 0000891532 PESI:PFMPolandMember 2021-10-01 2021-12-31 0000891532 us-gaap:DomesticCountryMember 2022-12-31 0000891532 us-gaap:StateAndLocalJurisdictionMember 2022-12-31 0000891532 PESI:SalesAgreementMember PESI:PFMLLCMember 2021-12-30 0000891532 PESI:SalesAgreementMember 2022-12-31 0000891532 PESI:SalesAgreementMember 2022-01-01 2022-12-31 0000891532 PESI:PFMPolandMember 2021-01-01 2021-12-31 0000891532 PESI:CanadianNuclearLaboratoriesLTDMember 2022-12-31 0000891532 PESI:CanadianNuclearLaboratoriesLTDMember 2022-01-01 2022-12-31 0000891532 PESI:AmericanInternationalGroupIncMember 2003-06-01 2003-06-30 0000891532 PESI:AmericanInternationalGroupIncMember 2022-12-31 0000891532 PESI:AmericanInternationalGroupIncMember 2021-12-31 0000891532 PESI:AmericanInternationalGroupIncMember PESI:ThousandandThreeClosurePolicyMember 2022-12-31 0000891532 PESI:AmericanInternationalGroupIncMember PESI:ThousandandThreeClosurePolicyMember 2021-12-31 0000891532 PESI:AmericanInternationalGroupIncMember PESI:ThousandandThreeClosurePolicyMember 2022-01-01 2022-12-31 0000891532 PESI:AmericanInternationalGroupIncMember PESI:ThousandandThreeClosurePolicyMember 2021-01-01 2021-12-31 0000891532 PESI:AmericanInternationalGroupIncMember 2022-01-01 2022-12-31 0000891532 PESI:AmericanInternationalGroupIncMember 2021-01-01 2021-12-31 0000891532 PESI:VicePresidentOfInformationSystemsMember PESI:DrDavidCentofantiMember 2022-01-01 2022-12-31 0000891532 PESI:VicePresidentOfInformationSystemsMember PESI:DrDavidCentofantiMember 2021-01-01 2021-12-31 0000891532 srt:ChiefExecutiveOfficerMember 2022-01-19 2022-01-20 0000891532 srt:ChiefExecutiveOfficerMember 2022-01-20 0000891532 srt:ChiefFinancialOfficerMember 2022-01-19 2022-01-20 0000891532 srt:ChiefFinancialOfficerMember 2022-01-20 0000891532 PESI:ExecutiveVicePresidentOfStrategicInitiativesMember 2022-01-19 2022-01-20 0000891532 PESI:ExecutiveVicePresidentOfStrategicInitiativesMember 2022-01-20 0000891532 PESI:ExecutiveVicePresidentOfNuclearAndTechnicalServicesMember 2022-01-19 2022-01-20 0000891532 PESI:ExecutiveVicePresidentOfNuclearAndTechnicalServicesMember 2022-01-20 0000891532 PESI:ExecutiveVicePresidentOfWasteTreatmentOperationsMember 2022-01-19 2022-01-20 0000891532 PESI:ExecutiveVicePresidentOfWasteTreatmentOperationsMember 2022-01-20 0000891532 PESI:SegmentsTotalMember 2022-01-01 2022-12-31 0000891532 us-gaap:CorporateAndOtherMember 2022-01-01 2022-12-31 0000891532 PESI:TreatmentMember 2022-12-31 0000891532 PESI:ServicesMember 2022-12-31 0000891532 PESI:SegmentsTotalMember 2022-12-31 0000891532 us-gaap:CorporateAndOtherMember 2022-12-31 0000891532 PESI:MedicalMember 2021-01-01 2021-12-31 0000891532 PESI:SegmentsTotalMember 2021-01-01 2021-12-31 0000891532 us-gaap:CorporateAndOtherMember 2021-01-01 2021-12-31 0000891532 PESI:TreatmentMember 2021-12-31 0000891532 PESI:ServicesMember 2021-12-31 0000891532 PESI:MedicalMember 2021-12-31 0000891532 PESI:SegmentsTotalMember 2021-12-31 0000891532 us-gaap:CorporateAndOtherMember 2021-12-31 0000891532 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember PESI:DomesticAndForeignGovernmentMember 2022-01-01 2022-12-31 0000891532 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember PESI:DomesticAndForeignGovernmentMember 2021-01-01 2021-12-31 0000891532 srt:ParentCompanyMember 2022-12-31 0000891532 srt:ParentCompanyMember 2021-12-31 0000891532 PESI:PaycheckProtectionProgramLoanMember 2022-01-01 2022-12-31 0000891532 PESI:EmployeeRetentionCreditMember 2022-01-01 2022-12-31 0000891532 country:DE 2022-01-01 2022-12-31 0000891532 country:DE 2021-01-01 2021-12-31 0000891532 country:IT 2022-01-01 2022-12-31 0000891532 country:IT 2021-01-01 2021-12-31 0000891532 us-gaap:SubsequentEventMember srt:ChiefExecutiveOfficerMember 2023-01-18 2023-01-19 0000891532 us-gaap:SubsequentEventMember srt:ChiefExecutiveOfficerMember 2023-01-19 0000891532 us-gaap:SubsequentEventMember srt:ChiefFinancialOfficerMember 2023-01-18 2023-01-19 0000891532 us-gaap:SubsequentEventMember srt:ChiefFinancialOfficerMember 2023-01-19 0000891532 us-gaap:SubsequentEventMember PESI:ExecutiveVicePresidentOfStrategicInitiativesMember 2023-01-18 2023-01-19 0000891532 us-gaap:SubsequentEventMember PESI:ExecutiveVicePresidentOfStrategicInitiativesMember 2023-01-19 0000891532 us-gaap:SubsequentEventMember PESI:ExecutiveVicePresidentOfNuclearAndTechnicalServicesMember 2023-01-18 2023-01-19 0000891532 us-gaap:SubsequentEventMember PESI:ExecutiveVicePresidentOfNuclearAndTechnicalServicesMember 2023-01-19 0000891532 us-gaap:SubsequentEventMember PESI:ExecutiveVicePresidentOfWasteTreatmentOperationsMember 2023-01-18 2023-01-19 0000891532 us-gaap:SubsequentEventMember PESI:ExecutiveVicePresidentOfWasteTreatmentOperationsMember 2023-01-19 0000891532 us-gaap:SubsequentEventMember PESI:IncentiveStockOptionAgreementMember 2023-01-18 2023-01-19 0000891532 us-gaap:SubsequentEventMember PESI:IncentiveStockOptionAgreementMember srt:ChiefExecutiveOfficerMember 2023-01-18 2023-01-19 0000891532 us-gaap:SubsequentEventMember PESI:IncentiveStockOptionAgreementMember srt:ChiefFinancialOfficerMember 2023-01-18 2023-01-19 0000891532 us-gaap:SubsequentEventMember PESI:IncentiveStockOptionAgreementMember PESI:ExecutiveVicePresidentOfStrategicInitiativesMember 2023-01-18 2023-01-19 0000891532 us-gaap:SubsequentEventMember PESI:IncentiveStockOptionAgreementMember PESI:ExecutiveVicePresidentOfWasteTreatmentOperationsMember 2023-01-18 2023-01-19 0000891532 us-gaap:SubsequentEventMember PESI:IncentiveStockOptionAgreementMember PESI:ExecutiveVicePresidentOfNuclearAndTechnicalServicesMember 2023-01-18 2023-01-19 0000891532 us-gaap:SubsequentEventMember PESI:IncentiveStockOptionAgreementMember 2023-01-19 0000891532 us-gaap:SubsequentEventMember PESI:RevisedLoanAgreementMember srt:MinimumMember 2023-03-21 0000891532 us-gaap:SubsequentEventMember PESI:RevisedLoanAgreementMember srt:MaximumMember 2023-03-21 0000891532 us-gaap:SubsequentEventMember PESI:RevisedLoanAgreementMember 2023-03-20 2023-03-21 0000891532 srt:ScenarioForecastMember us-gaap:RevolvingCreditFacilityMember 2023-06-30 0000891532 us-gaap:SubsequentEventMember PESI:RevisedLoanAgreementMember PESI:LenderMember 2023-03-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure PESI:Integer iso4217:CAD

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-K

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2022

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____ to _____

 

Commission File No. 1-11596

 

PERMA-FIX ENVIRONMENTAL SERVICES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   58-1954497

State or other jurisdiction

of incorporation or organization

 

(IRS Employer

Identification Number)

     
8302 Dunwoody Place, #250, Atlanta, GA   30350
(Address of principal executive offices)   (Zip Code)

 

(770) 587-9898

(Registrant’s telephone number)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of each exchange on which registered
Common Stock, $.001 Par Value   PESI   NASDAQ Capital Markets

 

Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☐ Yes ☒ No

 

Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. ☐ Yes ☒ No

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). ☒ Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer ☐ Accelerated Filer ☐ Non-accelerated Filer ☒ Smaller reporting company  Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards provided pursuant to Section 13(a) of the Exchange Act ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. 

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act). ☐ Yes ☒ No

 

The aggregate market value of the Registrant’s voting and non-voting common equity held by nonaffiliates of the Registrant computed by reference to the closing sale price of such stock as reported by NASDAQ as of the last business day of the most recently completed second fiscal quarter (June 30, 2022), was approximately $64,147,134). For the purposes of this calculation, all directors and executive officers of the Registrant (as indicated in Item 12) have been deemed to be affiliates. Such determination should not be deemed an admission that such directors and executive officers, are, in fact, affiliates of the Registrant. The Company’s Common Stock is listed on the NASDAQ Capital Markets.

 

As of February 14, 2023, there were 13,358,075 shares of the registrant’s Common Stock, $.001 par value, outstanding.

 

Documents incorporated by reference: None

 

 

 

 
 

 

PERMA-FIX ENVIRONMENTAL SERVICES, INC.

 

INDEX

 

  Page No.
PART I  
     
Item 1. Business 1
     
Item 1A. Risk Factors 7
     
Item 1B. Unresolved Staff Comments 16
     
Item 2. Properties 17
     
Item 3. Legal Proceedings 17
     
Item 4. Mine Safety Disclosure 17
     
PART II  
     
Item 5. Market for Registrant’s Common Equity and Related Stockholder Matters 17
     
Item 6. Selected Financial Data 18
     
Item 7. Management’s Discussion and Analysis of Financial Condition And Results of Operations 18
     
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 30
     
  Special Note Regarding Forward-Looking Statements 30
     
Item 8. Financial Statements and Supplementary Data 33
     
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 74
     
Item 9A. Controls and Procedures 74
     
Item 9B. Other Information 76
     
PART III  
     
Item 10. Directors, Executive Officers and Corporate Governance 76
     
Item 11. Executive Compensation 87
     
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 104
     
Item 13. Certain Relationships and Related Transactions, and Director Independence 107
     
Item 14. Principal Accountant Fees and Services 110
     
PART IV  
     
Item 15. Exhibits and Financial Statement Schedules 110

 

 
 

 

PART I

 

ITEM 1. BUSINESS

 

Company Overview and Principal Products and Services

 

Perma-Fix Environmental Services, Inc. (the Company, which may be referred to as we, us, or our), a Delaware corporation incorporated in December 1990, is an environmental and environmental technology know-how company.

 

The principal element of our business strategy consists of upgrading our facilities within our Treatment Segment to increase efficiency and modernize and expand treatment capabilities to meet the changing markets associated with the waste management industry. Within our Services Segment, we continue to bid on projects, increase competitive procurement effectiveness and broaden the market penetration within both the commercial and government sectors. The Company continues to remain focused on expansion into both commercial and international markets to supplement government spending in the United States of America (“USA”), from which a significant portion of the Company’s revenue is derived. This includes new services, new customers and increased market share in our current markets.

 

COVID-19 and Other Impacts

 

Our 2022 financial results continued to be impacted by COVID-19, among other things. Our Treatment Segment began to see steady improvements in waste receipts starting in the second quarter of 2022 from certain customers who had previously delayed waste shipments due, in part, from the impact of COVID-19. This positive trend was negatively impacted by occurrences of severe weather conditions which resulted in temporary delays in waste shipments from certain customers and a temporary shortage in skilled production personnel which peaked through the fourth quarter of 2022 at one of our facilities. In early part of 2022, our Services Segment continued to experience delays/curtailments in project work by certain customers since the award of projects to us late in the second quarter of 2021 due to COVID-19 impact and/or administrative delays. However, starting in the second quarter of 2022, work under these projects had resumed/increased as the pandemic impacts began to subside and has since reached full operational status. In 2022, we continued to realize delays in procurement and planning on behalf of our government clients that saw easing through the second half of the year. Heading into 2023, we expect to see continued improvements in waste receipts and continued increases in project work from contracts recently won and bids submitted in both segments that are awaiting awards, subject to potential COVID-19 and economic impacts. (See “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – COVID-19 and Other Impact” for a full discussion of COVID-19 and other impacts on the Company’s results of operations).

 

Segment Information and Foreign and Domestic Operations and Sales

 

For 2022, the Company has two reportable segments. In accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 280, “Segment Reporting”, we define an operating segment as:

 

a business activity from which we may earn revenue and incur expenses;
whose operating results are regularly reviewed by the chief operating decision maker “(CODM”) to make decisions about resources to be allocated and assess its performance; and
for which discrete financial information is available.

 

TREATMENT SEGMENT reporting includes:

 

-nuclear, low-level radioactive, mixed (waste containing both hazardous and low-level radioactive waste), hazardous and non-hazardous waste treatment, processing and disposal services primarily through four uniquely licensed (Nuclear Regulatory Commission or state equivalent) and permitted (U.S. Environmental Protection Agency (“EPA”) or state equivalent) treatment and storage facilities as follow: Perma-Fix of Florida, Inc. (“PFF”), Diversified Scientific Services, Inc., (“DSSI”), Perma-Fix Northwest Richland, Inc. (“PFNWR”) and Oak Ridge Environmental Waste Operations Center (“EWOC”); and
-Research & Development (“R&D”) activities to identify, develop and implement innovative waste processing techniques for problematic waste streams.

 

For 2022, the Treatment Segment accounted for $33,358,000, or 47.2%, of total revenue, as compared to $32,992,000, or 45.7%, of total revenue for 2021. See “Dependence Upon a Single or Few Customers” for further details and a discussion as to our Segments’ contracts with government clients (domestic and foreign) or with others as a subcontractor to government clients.

 

1
 

 

SERVICES SEGMENT, which includes:

 

-Technical services, which include:

 

professional radiological measurement and site survey of large government and commercial installations using advanced methods, technology and engineering;
health physics services including health physicists, radiological engineers, nuclear engineers and health physics technicians support to government and private radioactive materials licensees;
integrated Occupational Safety and Health services including industrial hygiene (“IH”) assessments; hazardous materials surveys, e.g., exposure monitoring; lead and asbestos management/abatement oversight; indoor air quality evaluations; health risk and exposure assessments; health & safety plan/program development, compliance auditing and training services; and Occupational Safety and Health Administration (“OSHA”) citation assistance;
global technical services providing consulting, engineering (civil, nuclear, mechanical, chemical, radiological and environmental), project management, waste management, environmental, and decontamination and decommissioning (“D&D”) field, technical, and management personnel and services to commercial and government customers; and
waste management services to commercial and governmental customers.
- Nuclear services, which include:
D&D of government and commercial facilities impacted with radioactive material and hazardous constituents including engineering, technology applications, specialty services, logistics, transportation, processing and disposal; and
license termination support of radioactive material licensed and federal facilities over the entire cycle of the termination process: project management, planning, characterization, waste stream identification and delineation, remediation/demolition, final status survey, compliance demonstration, reporting, transportation, disposal and emergency response.

 

-A company owned equipment calibration and maintenance laboratory that services, maintains, calibrates, and sources (i.e., rental) health physics, IH and customized nuclear, environmental, and occupational safety and health (“NEOSH”) instrumentation.

 

For 2022, the Services Segment accounted for $37,241,000, or 52.8%, of total revenue, as compared to $39,199,000, or 54.3%, of total revenue for 2021. See “Dependence Upon a Single or Few Customers” for further details and a discussion as to our Segments’ contracts with government clients (domestic and foreign) or with others as a subcontractor to government clients.

 

Our Treatment and Services Segments provide services to research institutions, commercial companies, public utilities, and governmental agencies (domestic and foreign), including the U.S. Department of Energy (“DOE”) and U.S. Department of Defense (“DOD”). The distribution channels for our services are through direct sales to customers or via intermediaries.

 

Our corporate office is located at 8302 Dunwoody Place, Suite 250, Atlanta, Georgia 30350.

 

Foreign Revenue and Initiative

 

Our consolidated revenue for 2022 and 2021 included approximately $406,000, or 0.6%, and $9,277,000, or 12.9%, respectively, from Canadian customers.

 

2
 

 

During March 2022, we signed a joint venture term sheet addressing plans to partner with Springfields Fuels Limited (“SFL”), an affiliate of Westinghouse Electric Company LLC, to develop and manage a nuclear waste-materials treatment facility (the “Facility”) in the United Kingdom. The Facility is for the purpose of expanding the partners’ waste treatment capabilities for the European nuclear market. It is expected that upon finalization of a partnership agreement, SFL will have an ownership interest of fifty-five (55) percent and our interest will be forty-five (45) percent. The finalization, form and capitalization of this unpopulated partnership is subject to numerous conditions, including but not limited to, winning a certain contract, completion and execution of a definitive agreement and facility design, granting of required regulatory, lender or permitting approvals and updated cost and profitability analysis based on current and forecast future economic conditions. Upon finalization of this venture, we will be required to make an investment in this venture. The amount of our investment, the period of which it is to be made and the method of funding are to be determined.

 

Seasonal Factors of our Business

 

Our operations are generally subject to seasonal factors. See “Risk Factors – Risks Related to our Business and Operations – Our operations are subject to seasonal factors, which causes our revenues to fluctuate” for a discussion of our seasonal factors.

 

Permits and Licenses

 

Waste management service companies are subject to extensive, evolving and increasingly stringent federal, state, and local environmental laws and regulations. Such federal, state and local environmental laws and regulations govern our activities regarding the treatment, storage, processing, disposal and transportation of hazardous, non-hazardous and radioactive wastes, and require us to obtain and maintain permits, licenses and/or approvals in order to conduct our waste activities. We are dependent on our permits and licenses discussed below in order to operate our businesses. Failure to obtain and maintain our permits or approvals would have a material adverse effect on us, our operations, and financial condition. The permits and licenses have terms ranging from one to ten years, and provided that we maintain a reasonable level of compliance, renew with minimal effort, and cost. We believe that these permit and license requirements represent a potential barrier to entry for possible competitors.

 

PFF, located in Gainesville, Florida, operates its hazardous, mixed and low-level radioactive waste activities under a Resource Conservation and Recovery Act (“RCRA”) Part B permit, Toxic Substances Control Act (“TSCA”) authorization, Restricted RX Drug Distributor-Destruction license, biomedical, and a radioactive materials license issued by the State of Florida.

 

DSSI, located in Kingston, Tennessee, conducts mixed and low-level radioactive waste storage and treatment activities under RCRA Part B permits and a radioactive materials license issued by the State of Tennessee Department of Environment and Conservation, Division of radiological health. Co-regulated TSCA Polychlorinated Biphenyl (“PCB”) wastes are also managed for PCB destruction under EPA Approval.

 

PFNWR, located in Richland, Washington, operates a low-level radioactive waste processing facility as well as a mixed waste processing facility. Radioactive material processing is authorized under radioactive materials licenses issued by the State of Washington and mixed waste processing is additionally authorized under a RCRA Part B permit with TSCA authorization issued jointly by the State of Washington and the EPA.

 

EWOC, located in Oak Ridge, Tennessee, operates a low-level radioactive waste material processing facility. Radioactive material processing is authorized under radioactive material licenses issued by the State of Tennessee Department of Environmental and Conservation, Division of radiological health.

 

The combination of RCRA Part B hazardous waste permits, TSCA authorizations, and radioactive material licenses held by the Company and its subsidiaries comprising our Treatment Segment is very difficult to obtain for a single facility and make this Segment unique.

 

We believe that the permitting and licensing requirements, and the cost to obtain such permits, are barriers to the entry of hazardous waste and radioactive and mixed waste activities as presently operated by our waste treatment subsidiaries. If the permit requirements for hazardous waste treatment, storage, and disposal (“TSD”) activities and/or the licensing requirements for the handling of low-level radioactive matters are eliminated or if such licenses or permits were made less rigorous to obtain, we believe such would allow companies to enter into these markets and provide greater competition.

 

3
 

 

Number of Employees

 

At December 31, 2022, we employed approximately 296 employees, of whom 287 are full-time employees and 9 are part-time/temporary employees. None of our employees are unionized.

 

Environmental, Social and Governance (“ESG”)

 

During 2022, we continued to improve our ESG performance. Our ESG subcommittee under our Corporate Governance and Nominating Committee continues to provide guidance on ESG management. Our executive team is responsible for the development of a strategic roadmap for ESG efforts with support from management from key functional areas. The key areas of focus under our ESG initiatives continue to be health and safety, environmental performance, DEI (diversity, equality and inclusion), talent retention and development, corporate governance and climate-forward service development that support our customers’ transition to low carbon economy. Our executive team is involved in policy planning and coordination of corporate-wide ESG efforts. See our website at https://www.perma-fix.com/esg.aspx for some highlights of our ESG initiatives as well as our policies under our ESG as we continue to improve our ESG initiatives. The information on our website is not part of, or incorporated by reference in this Form 10-K.

 

Dependence Upon a Single or Few Customers

 

Our Treatment and Services Segments have significant relationships with the U.S. governmental authorities. Our Services Segment also had significant relationships with the Canadian government authorities. A significant amount of our revenues from our Treatment and Services Segments are generated indirectly as subcontractors for others who are prime contractors to government authorities, particularly the DOE and DOD, or directly as the prime contractor to government authorities. The contracts that we are a party to with others as subcontractors to the U.S federal government or directly with the U.S federal government generally provide that the government may terminate the contract at any time for convenience at the government’s option. The contracts/task order agreements (“TOA”) that we are a party to with Canadian governmental authorities also generally provide that the government authorities may terminate the contracts/task order agreements at any time for any reason for convenience. Project work under TOAs with Canadian government authority has substantially been completed. A significant account receivable due to our Perma-Fix Canada, Inc. (“PF Canada”) is subject to continuing negotiations. See “Known Trends and Uncertainties – Perma-Fix Canada, Inc. (“PF Canada”)” in Part II – Item 7 – “Management’s Discussion and Analysis of financial Condition and Results of Operations” for additional discussion as to a terminated Canadian TOA. Our inability to continue under existing contracts that we have with U.S government authorities (directly or indirectly as a subcontractor) or significant reductions in the level of governmental funding in any given year could have a material adverse impact on our operations and financial condition.

 

We performed services relating to waste generated by government clients (domestic and foreign (primarily Canadian)), either indirectly for others as a subcontractor to government entities or directly as a prime contractor to government entities, representing approximately $60,030,000, or 85.0%, of our total revenue during 2022, as compared to $60,812,000, or 84.2%, of our total revenue during 2021.

 

Our revenues are project/event based where the completion of one contract with a specific customer may be replaced by another contract with a different customer from year to year.

 

4
 

 

Competitive Conditions

 

The Treatment Segment’s largest competitor is EnergySolutions which operates treatment facilities in Oak Ridge, TN and Erwin, TN and treatment/disposal facilities for low level radioactive waste in Clive, UT and Barnwell, SC. Waste Control Specialists, which has licensed treatment/disposal capabilities for low level radioactive waste in Andrews, TX, is also a competitor in the treatment market with increasing market share. These two competitors also provide us with options for disposal of our treated nuclear waste. The Treatment Segment treats and disposes of DOE generated waste largely at DOE owned sites. Our Treatment Segment currently solicits business primarily on a North America basis with both government and commercial clients; however, we continue to focus on emerging international markets for additional work.

 

Our Services Segment is engaged in highly competitive businesses in which a number of our government contracts and some of our commercial contracts are awarded through competitive bidding processes. The extent of such competition varies according to the industries and markets in which our customers operate as well as the geographic areas in which we operate. The degree and type of competition we face is also often influenced by the project specification being bid on and the different specialty skill sets of each bidder for which our Services Segment competes, especially projects subject to the governmental bid process. We also have the ability to prime federal government small business procurements (small business set asides). Based on past experience, we believe that large businesses are more willing to team with small businesses in order to be part of these often-substantial procurements. There are a number of qualified small businesses in our market that will provide intense competition that may provide a challenge to our ability to maintain strong growth rates and acceptable profit margins. For international business there are additional competitors, many from within the country the work is to be performed, making winning work in foreign countries more challenging. If our Services Segment is unable to meet these competitive challenges, it could lose market share and experience an overall reduction in its profits.

 

Certain Environmental Expenditures and Potential Environmental Liabilities

 

Environmental Liabilities

 

We have three remediation projects, which are currently in progress relating to our Perma-Fix of Dayton, Inc. (“PFD”), Perma-Fix of Memphis, Inc. (“PFM”), and Perma-Fix South Georgia, Inc. (“PFSG”) subsidiaries, which are all included within our discontinued operations. These remediation projects principally entail the removal/remediation of contaminated soil and, in most cases, the remediation of surrounding ground water. These remediation activities are closely reviewed and monitored by the applicable state regulators.

 

At December 31, 2022, we had total accrued environmental remediation liabilities of $861,000, a decrease of $15,000 from the December 31, 2021 balance of $876,000. The decrease represents payments for remediation projects. At December 31, 2022, $112,000 of the total accrued environmental liabilities was recorded as current.

 

The nature of our business exposes us to significant cost to comply with governmental environmental laws, rules and regulations and risk of liability for damages. Such potential liability could involve, for example, claims for cleanup costs, personal injury or damage to the environment in cases where we are held responsible for the release of hazardous materials; claims of employees, customers or third parties for personal injury or property damage occurring in the course of our operations; and claims alleging negligence or professional errors or omissions in the planning or performance of our services. In addition, we could be deemed a potentially responsible party (“PRP”) for the costs of required cleanup of properties, which may be contaminated by hazardous substances generated or transported by us to a site we selected, including properties owned or leased by us. We could also be subject to fines and civil penalties in connection with violations of regulatory requirements.

 

R&D

 

Innovation and technical know-how by our operations is very important to the success of our business. Our goal is to discover, develop and bring to market innovative ways to process waste that address unmet environmental needs. We conduct research internally, and also through collaborations with other third parties. The majority of our research activities are performed as we receive new and unique waste to treat. Our competitors also devote resources to R&D and many such competitors have greater resources at their disposal than we do. R&D totaled $336,000 and $746,000 for 2022 and 2021, respectively.

 

5
 

 

Governmental Regulation

 

Environmental companies, such as us, and their customers are subject to extensive and evolving environmental laws and regulations by a number of federal, state and local environmental, safety and health agencies, the principal of which being the EPA. These laws and regulations largely contribute to the demand for our services. Although our customers remain responsible by law for their environmental problems, we must also comply with the requirements of those laws applicable to our services. We cannot predict the extent to which our operations may be affected by future enforcement policies as applied to existing laws or by the enactment of new environmental laws and regulations. Moreover, any predictions regarding possible liability are further complicated by the fact that under current environmental laws we could be jointly and severally liable for certain activities of third parties over whom we have little or no control. Although we believe that we are currently in substantial compliance with applicable laws and regulations, we could be subject to fines, penalties or other liabilities or could be adversely affected by existing or subsequently enacted laws or regulations. The principal environmental laws affecting our customers and us are briefly discussed below.

 

The Resource Conservation and Recovery Act of 1976, as amended (“RCRA”)

 

RCRA and its associated regulations establish a strict and comprehensive permitting and regulatory program applicable to companies, such as us, that treat, store or dispose of hazardous waste. The EPA has promulgated regulations under RCRA for new and existing treatment, storage and disposal facilities including incinerators, storage and treatment tanks, storage containers, storage and treatment surface impoundments, waste piles and landfills. Every facility that treats, stores or disposes of hazardous waste must obtain a RCRA permit or must obtain interim status from the EPA, or a state agency, which has been authorized by the EPA to administer its program, and must comply with certain operating, financial responsibility and closure requirements.

 

The Comprehensive Environmental Response, Compensation and Liability Act of 1980 (“CERCLA,” also referred to as the “Superfund Act”)

 

CERCLA governs the cleanup of sites at which hazardous substances are located or at which hazardous substances have been released or are threatened to be released into the environment. CERCLA authorizes the EPA to compel responsible parties to clean up sites and provides for punitive damages for noncompliance. CERCLA imposes joint and several liabilities for the costs of clean up and damages to natural resources.

 

Health and Safety Regulations

 

The operation of our environmental activities is subject to the requirements of the OSHA and comparable state laws. Regulations promulgated under OSHA by the Department of Labor require employers of persons in the transportation and environmental industries, including independent contractors, to implement hazard communications, work practices and personnel protection programs in order to protect employees from equipment safety hazards and exposure to hazardous chemicals.

 

Atomic Energy Act

 

The Atomic Energy Act of 1954 governs the safe handling and use of Source, Special Nuclear and Byproduct materials in the U.S. and its territories. This act authorized the Atomic Energy Commission (now the Nuclear Regulatory Commission “USNRC”) to enter into “Agreements with states to carry out those regulatory functions in those respective states except for Nuclear Power Plants and federal facilities like the VA hospitals and the DOE operations.” The State of Florida Department of Health (with the USNRC oversight), Office of Radiation Control, regulates the licensing and radiological program of the PFF facility; the State of Tennessee (with the USNRC oversight), Tennessee Division of Radiological Health, regulates licensing and the radiological program of the DSSI facility and the EWOC facility; and the State of Washington (with the USNRC oversight) Department of Health, regulates licensing and the radiological operations of the PFNWR facility.

 

Other Laws

 

Our activities are subject to other federal environmental protection and similar laws, including, without limitation, the Clean Water Act, the Clean Air Act, the Hazardous Materials Transportation Act and the TSCA. Many states have also adopted laws for the protection of the environment which may affect us, including laws governing the generation, handling, transportation and disposition of hazardous substances and laws governing the investigation and cleanup of, and liability for, contaminated sites. Some of these state provisions are broader and more stringent than existing federal law and regulations. Our failure to conform our services to the requirements of any of these other applicable federal or state laws could subject us to substantial liabilities which could have a material adverse effect on us, our operations and financial condition. In addition to various federal, state and local environmental regulations, our hazardous waste transportation activities are regulated by the U.S. Department of Transportation, the Interstate Commerce Commission and transportation regulatory bodies in the states in which we operate. We cannot predict the extent to which we may be affected by any law or rule that may be enacted or enforced in the future, or any new or different interpretations of existing laws or rules.

 

6
 

 

ITEM 1A. RISK FACTORS

 

The following are certain risk factors that could affect our business, financial performance, and results of operations. These risk factors should be considered in connection with evaluating the forward-looking statements contained in this Form 10-K, as the forward-looking statements are based on current expectations, and actual results and conditions could differ materially from the current expectations. Investing in our securities involves a high degree of risk, and before making an investment decision, you should carefully consider these risk factors as well as other information we include or incorporate by reference in the other reports we file with the Securities and Exchange Commission (the “Commission”).

 

Risks Relating to our Business and Operations

 

Failure to maintain our financial assurance coverage that we are required to have in order to operate our permitted treatment, storage and disposal facilities could have a material adverse effect on us.

 

We maintain finite risk insurance policies and bonding mechanisms which provide financial assurance to the applicable states for our permitted facilities in the event of unforeseen closure of those facilities. We are required to provide and to maintain financial assurance that guarantees to the state that in the event of closure, our permitted facilities will be closed in accordance with the regulations. In the event that we are unable to obtain or maintain our financial assurance coverage for any reason, this could materially impact our operations and our permits which we are required to have in order to operate our treatment, storage, and disposal facilities.

 

Natural disasters and/or public health events, including COVID-19 and their direct and indirect macroeconomic impacts, could continue to negatively impact our business and results of operations.

 

Public health threats and outbreaks such as COVID-19 and natural disasters such as hurricanes and severe weather conditions have negatively impacted our results of operations. The direct impacts of these such events resulted in delayed waste shipments from certain of our customers and delays in procurement, contract awards and planning on behalf of our government clients which negatively impacted our revenue. Residual and lingering macroeconomic effects from these such events could continue to impact supply chain, workforce availability, and/or increased costs which could have a downward effect on our business, financial condition and results of operations. We may attempt to increase our sales prices in order to maintain satisfactory margin; however, competitive pressures in our industry may have the effect of inhibiting our ability to reflect these increased costs in the prices of our services that we provide to our customers and therefore reduce our profitability.

 

If we cannot maintain adequate insurance coverage, we will be unable to continue certain operations.

 

Our business exposes us to various risks, including claims for causing damage to property and injuries to persons that may involve allegations of negligence or professional errors or omissions in the performance of our services. Such claims could be substantial. We believe that our insurance coverage is presently adequate and similar to, or greater than, the coverage maintained by other companies in the industry of our size. If we are unable to obtain adequate or required insurance coverage in the future, or if our insurance is not available at affordable rates, we would violate our permit conditions and other requirements of the environmental laws, rules, and regulations under which we operate. Such violations would render us unable to continue certain of our operations. These events would have a material adverse effect on our financial condition.

 

7
 

 

The inability to maintain existing government contracts or win new government contracts over an extended period could have a material adverse effect on our operations and adversely affect our future revenues.

 

A material amount of our Treatment and Services Segments’ revenues are generated through various government contracts or subcontracts. Our revenues from governmental contracts and subcontracts relating to governmental facilities within our segments were approximately $60,030,000, or 85.0%, and $60,812,000, or 84.2%, of our consolidated revenues for 2022 and 2021, respectively. Most of our government contracts or our subcontracts granted under government contracts are awarded through a regulated competitive bidding process. Some government contracts are awarded to multiple competitors, which increase overall competition and pricing pressure and may require us to make sustained post-award efforts to realize revenues under these government contracts. Contracts with, or subcontracts involving, the U.S federal government are generally terminable for convenience at any time at the option of the governmental agency. The contracts/TOAs that we are a party to with Canadian governmental authorities also generally provide that the government authorities may terminate the contracts/TOAs at any time for any reason for convenience. If we fail to maintain or replace these relationships, or if a material contract is terminated or renegotiated in a manner that is materially adverse to us, our revenues and future operations could be materially adversely affected.

 

Our existing and future customers may reduce or halt their spending on hazardous waste and nuclear services with outside vendors, including us.

 

A variety of factors may cause our existing or future customers (including government clients) to reduce or halt their spending on hazardous waste and nuclear services from outside vendors, including us. These factors include, but are not limited to:

 

accidents, terrorism, natural disasters or other incidents occurring at nuclear facilities or involving shipments of nuclear materials;
failure of government to approve necessary budgets, or to reduce the amount of the budget necessary, to fund remediation sites, including DOE and DOD sites;
civic opposition to or changes in government policies regarding nuclear operations;
a reduction in demand for nuclear generating capacity; or
failure to perform under existing contracts, directly or indirectly, with the government.

 

These events could result in or cause government clients to terminate or cancel existing contracts involving us to treat, store or dispose of contaminated waste and/or to perform remediation projects, at one or more of government sites. These events also could adversely affect us to the extent that they result in the reduction or elimination of contractual requirements, lower demand for nuclear services, burdensome regulation, disruptions of shipments or production, increased operational costs or difficulties or increased liability for actual or threatened property damage or personal injury.

 

Economic downturns, reductions in government funding or other events (including COVID-19) beyond our control could have a material negative impact on our businesses.

 

Demand for our services has been, and we expect that demand will continue to be, subject to significant fluctuations due to a variety of factors beyond our control, including, without limitation, economic conditions, reductions in the budget for spending to remediate federal sites due to numerous reasons including, without limitation, the substantial deficits that the federal government has and is continuing to incur. During economic downturns, large budget deficits that the federal government and many states are experiencing, and other events beyond our control, including, but not limited to the impact from COVID-19, the ability of private and government entities to spend on waste services, including nuclear services, may decline significantly. Our operations depend, in large part, upon governmental funding (for example, the annual budget of the DOE) or specifically mandated levels for different programs that are important to our business could have a material adverse impact on our business, financial position, results of operations and cash flow.

 

The loss of one or a few customers could have an adverse effect on us.

 

One or a few governmental customers or governmental related customers have in the past, and may in the future, account for a significant portion of our revenue in any one year or over a period of several consecutive years. Because customers generally contract with us for specific projects, we may lose these significant customers from year to year as their projects with us are completed. Our inability to replace the business with other similar significant projects could have an adverse effect on our business and results of operations.

 

8
 

 

We are a holding company and depend, in large part, on receiving funds from our subsidiaries to fund our indebtedness.

 

Because we are a holding company and operations are conducted through our subsidiaries, our ability to meet our obligations depends, in large part, on the operating performance and cash flows of our subsidiaries.

 

Our Treatment Segment has limited end disposal sites to utilize to dispose of its waste which could significantly impact our results of operations.

 

Our Treatment Segment has limited options available for disposal of our nuclear waste. Currently, there are only four commercial disposal sites for our low-level radioactive waste and six commercial disposal sites for our very low-level activity waste we receive from non-governmental sites, allowing us to take advantage of the pricing competition between these sites. If one or more of these commercial disposal sites ceases to accept waste or closes for any reason or refuses to accept the waste of our Treatment Segment, for any reason, we would have limited remaining site to dispose of our nuclear waste. With limited end disposal site to dispose of our waste, we could be subject to significantly increased costs which could negatively impact our results of operations.

 

Our operations are subject to seasonal factors, which cause our revenues to fluctuate.

 

We have historically experienced reduced revenues and losses during the first and fourth quarters of our fiscal years due to a seasonal slowdown in operations from poor weather conditions, overall reduced activities during these periods resulting from holiday periods, and finalization of government budgets during the fourth quarter of each year. During our second and third fiscal quarters there has historically been an increase in revenues and operating profits. If we do not continue to have increased revenues and profitability during the second and third fiscal quarters, this could have a material adverse effect on our results of operations and liquidity.

 

We are engaged in highly competitive businesses and typically must bid against other competitors to obtain major contracts.

 

We are engaged in highly competitive business in which most of our government contracts and some of our commercial contracts are awarded through competitive bidding processes. We compete with national, regional firms and some international firms with nuclear and/or hazardous waste services practices, as well as small or local contractors. Some of our competitors have greater financial and other resources than we do, which can give them a competitive advantage. In addition, even if we are qualified to work on a new government contract, we might not be awarded the contract because of existing government policies designed to protect certain types of businesses and under-represented minority contractors. Although we believe we have the ability to certify and bid government contract as a small business, there are a number of qualified small businesses in our market that will provide intense competition. For international business, which we continue to focus on, there are additional competitors, many from within the country the work is to be performed, making winning work in foreign countries more challenging. Competition places downward pressure on our contract prices and profit margins. If we are unable to meet these competitive challenges, we could lose market share and experience on overall reduction in our profits.

 

We bear the risk of cost overruns in fixed-price contracts. We may experience reduced profits or, in some cases, losses under these contracts if costs increase above our estimates.

 

Our revenues may be earned under contracts that are fixed-price or maximum price in nature. Fixed-price contracts expose us to a number of risks not inherent in cost-reimbursable contracts. Under fixed price and guaranteed maximum-price contracts, contract prices are established in part on cost and scheduling estimates which are based on a number of assumptions, including assumptions about future economic conditions, prices and availability of labor, equipment and materials, and other exigencies. If these estimates prove inaccurate, or if circumstances change such as unanticipated technical problems, difficulties in obtaining permits or approvals, changes in laws or labor conditions, continued supply chain interruptions, weather delays, cost of raw materials, our suppliers’ or subcontractors’ inability to perform, and/or other events beyond our control, such as the impact of COVID-19, cost overruns may occur and we could experience reduced profits or, in some cases, a loss for that project. Errors or ambiguities as to contract specifications can also lead to cost-overruns.

 

9
 

 

Adequate bonding is necessary for us to win certain types of new work and support facility closure requirements.

 

We are often required to provide performance bonds to customers under certain of our contracts, primarily within our Services Segment. These surety instruments indemnify the customer if we fail to perform our obligations under the contract. If a bond is required for a particular project and we are unable to obtain it due to insufficient liquidity or other reasons, we may not be able to pursue that project. In addition, we provide bonds to support financial assurance in the event of facility closure pursuant to state requirements. We currently have a bonding facility but, the issuance of bonds under that facility is at the surety’s sole discretion. Moreover, due to events that affect the insurance and bonding markets generally, bonding may be more difficult to obtain in the future or may only be available at significant additional cost. There can be no assurance that bonds will continue to be available to us on reasonable terms. Our inability to obtain adequate bonding and, as a result, to bid on new work could have a material adverse effect on our business, financial condition and results of operations.

 

If we cannot maintain our governmental permits or cannot obtain required permits, we may not be able to continue or expand our operations.

 

We are a nuclear services and waste management company. Our business is subject to extensive, evolving, and increasingly stringent federal, state, and local environmental laws and regulations. Such federal, state, and local environmental laws and regulations govern our activities regarding the treatment, storage, recycling, disposal, and transportation of hazardous and non-hazardous waste and low-level radioactive waste. We must obtain and maintain permits or licenses to conduct these activities in compliance with such laws and regulations. Failure to obtain and maintain the required permits or licenses would have a material adverse effect on our operations and financial condition. If any of our facilities are unable to maintain currently held permits or licenses or obtain any additional permits or licenses which may be required to conduct its operations, we may not be able to continue those operations at these facilities, which could have a material adverse effect on us.

 

Risks Related to Laws and Regulations

 

As a government contractor, we are subject to extensive government regulation, and our failure to comply with applicable regulations could subject us to penalties that may restrict our ability to conduct our business.

 

Our governmental contracts or subcontracts relating to DOE sites, are a significant part of our business. Allowable costs under U.S. government contracts are subject to audit by the U.S. government. If these audits result in determinations that costs claimed as reimbursable are not allowed costs or were not allocated in accordance with applicable regulations, we could be required to reimburse the U.S. government for amounts previously received.

 

Governmental contracts or subcontracts involving governmental facilities are often subject to specific procurement regulations, contract provisions and a variety of other requirements relating to the formation, administration, performance and accounting of these contracts. Many of these contracts include express or implied certifications of compliance with applicable regulations and contractual provisions. If we fail to comply with any regulations, requirements or statutes, our existing governmental contracts or subcontracts involving governmental facilities could be terminated or we could be suspended from government contracting or subcontracting. If one or more of our governmental contracts or subcontracts are terminated for any reason, or if we are suspended or debarred from government work, we could suffer a significant reduction in expected revenues and profits. Furthermore, as a result of our governmental contracts or subcontracts involving governmental facilities, claims for civil or criminal fraud may be brought by the government or violations of these regulations, requirements or statutes.

 

10
 

 

Changes in environmental regulations and enforcement policies could subject us to additional liability and adversely affect our ability to continue certain operations.

 

We cannot predict the extent to which our operations may be affected by future governmental enforcement policies as applied to existing environmental laws, by changes to current environmental laws and regulations, or by the enactment of new environmental laws and regulations. Any predictions regarding possible liability under such laws are complicated further by current environmental laws which provide that we could be liable, jointly and severally, for certain activities of third parties over whom we have limited or no control.

 

Our businesses subject us to substantial potential environmental liability.

 

Our business of rendering services in connection with management of waste, including certain types of hazardous waste, low-level radioactive waste, and mixed waste (waste containing both hazardous and low-level radioactive waste), subjects us to risks of liability for damages. Such liability could involve, without limitation:

 

claims for clean-up costs, personal injury or damage to the environment in cases in which we are held responsible for the release of hazardous or radioactive materials;
claims of employees, customers, or third parties for personal injury or property damage occurring in the course of our operations; and 
claims alleging negligence or professional errors or omissions in the planning or performance of our services.

 

Our operations are subject to numerous environmental laws and regulations. We have in the past, and could in the future, be subject to substantial fines, penalties, and sanctions for violations of environmental laws and substantial expenditures as a responsible party for the cost of remediating any property which may be contaminated by hazardous substances generated by us and disposed at such property, or transported by us to a site selected by us, including properties we own or lease.

 

As our operations expand, we may be subject to increased litigation, which could have a negative impact on our future financial results.

 

Our operations are highly regulated and we are subject to numerous laws and regulations regarding procedures for waste treatment, storage, recycling, transportation, and disposal activities, all of which may provide the basis for litigation against us. In recent years, the waste treatment industry has experienced a significant increase in so-called “toxic-tort” litigation as those injured by contamination seek to recover for personal injuries or property damage. We believe that, as our operations and activities expand, there will be a similar increase in the potential for litigation alleging that we have violated environmental laws or regulations or are responsible for contamination or pollution caused by our normal operations, negligence or other misconduct, or for accidents, which occur in the course of our business activities. Such litigation, if significant and not adequately insured against, could adversely affect our financial condition and our ability to fund our operations. Protracted litigation would likely cause us to spend significant amounts of our time, effort, and money. This could prevent our management from focusing on our operations and expansion.

 

If environmental regulation or enforcement is relaxed, the demand for our services could decrease.

 

The demand for our services is substantially dependent upon the public’s concern with, and the continuation and proliferation of, the laws and regulations governing the treatment, storage, recycling, and disposal of hazardous, non-hazardous, and low-level radioactive waste. A decrease in the level of public concern, the repeal or modification of these laws, or any significant relaxation of regulations relating to the treatment, storage, recycling, and disposal of hazardous waste and low-level radioactive waste could significantly reduce the demand for our services and could have a material adverse effect on our operations and financial condition. We are not aware of any current federal or state government or agency efforts in which a moratorium or limitation has been, or will be, placed upon the creation of new hazardous or radioactive waste regulations that would have a material adverse effect on us; however, no assurance can be made that such a moratorium or limitation will not be implemented in the future.

 

We and our customers operate in a politically sensitive environment, and the public perception of nuclear power and radioactive materials can affect our customers and us.

 

We and our customers operate in a politically sensitive environment. Opposition by third parties to particular projects can limit the handling and disposal of radioactive materials. Adverse public reaction to developments in the disposal of radioactive materials, including any high-profile incident involving the discharge of radioactive materials, could directly affect our customers and indirectly affect our business. Adverse public reaction also could lead to increased regulation or outright prohibition, limitations on the activities of our customers, more onerous operating requirements or other conditions that could have a material adverse impact on our customers’ and our business.

 

11
 

 

The elimination or any modification of the Price-Anderson Acts indemnification authority could have adverse consequences for our business.

 

The Atomic Energy Act of 1954, as amended, or the AEA, comprehensively regulates the manufacture, use, and storage of radioactive materials. The Price-Anderson Act (“PAA”) supports the nuclear services industry by offering broad indemnification to DOE contractors for liabilities arising out of nuclear incidents at DOE nuclear facilities. That indemnification protects DOE prime contractor, but also similar companies that work under contract or subcontract for a DOE prime contract or transporting radioactive material to or from a site. The indemnification authority of the DOE under the PAA was extended through 2025 by the Energy Policy Act of 2005.

 

Under certain conditions, the PAA’s indemnification provisions may not apply to our processing of radioactive waste at governmental facilities, and may not apply to liabilities that we might incur while performing services as a contractor for the DOE and the nuclear energy industry. If an incident or evacuation is not covered under PAA indemnification, we could be held liable for damages, regardless of fault, which could have an adverse effect on our results of operations and financial condition. If such indemnification authority is not applicable in the future, our business could be adversely affected if the owners and operators of new facilities fail to retain our services in the absence of commercial adequate insurance and indemnification.

 

Risks Relating to our Financial Performance and Position and Need for Financing

 

We sustained a loss in 2022, and if we are unable to improve our results of operations in 2023, it could have a material adverse effect on the Company.

 

In 2022, we sustained a loss in our results of operations. We believe that we will be able to improve our results of operations in 2023. If we are unable to substantially improve our results in 2023, it could have a material adverse effect on the Company and our operations.

 

If any of our permits, other intangible assets, and tangible assets becomes impaired, we may be required to record significant charges to earnings.

 

Under accounting principles generally accepted in the United States (“U.S. GAAP”), we review our intangible and tangible assets for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. Our permits are tested for impairment at least annually. Factors that may be considered a change in circumstances, indicating that the carrying value of our permit, other intangible assets, and tangible assets may not be recoverable, include a decline in stock price and market capitalization, reduced future cash flow estimates, and slower growth rates in our industry. We may be required, in the future, to record impairment charges in our financial statements, in which any impairment of our permit, other intangible assets, and tangible assets is determined. Such impairment charges could negatively impact our results of operations.

 

Breach of any of the covenants in our credit facility could result in a default, triggering repayment of outstanding debt under the credit facility and the termination of our credit facility.

 

Our credit facility with our bank contains financial covenants. A breach of any of these covenants could result in a default under our credit facility triggering our lender to immediately require the repayment of all outstanding debt under our credit facility and terminate all commitments to extend further credit. We failed to meet our quarterly fixed charge coverage ratio (“FCCR”) requirement for the second quarter of 2022; however, our lender waived this non-compliance. We were not required to perform testing of our FCCR in the first and third quarters of 2022. As a result of a recent amendment that we entered into with our lender in March 2023, we were not required to perform testing our FCCR for the fourth quarter of 2022. Additionally, in the past, when we also failed to meet our minimum FCCR requirement in certain instances, our lender has either waived these instances of non-compliance or provided certain amendments to our FCCR requirements which enabled us to meet our quarterly FCCR requirements. Also, our lender has in the past waived our FCCR testing requirement in certain quarters. If we fail to meet any of our financial covenants going forward, including the minimum quarterly FCCR requirement, and our lender does not further waive the non-compliance or further revise our covenant requirement so that we are in compliance, our lender could accelerate the payment of our borrowings under our credit facility and terminate our credit facility. In such event, we may not have sufficient liquidity to repay our debt under our credit facility and other indebtedness and/or operate our business.

 

12
 

 

Our debt and borrowing availability under our credit facility could adversely affect our operations.

 

At December 31, 2022, our aggregate consolidated debt was approximately $1,039,000. Our Second Amended and Restated Revolving Credit, Term Loan and Security Agreement dated May 8, 2020, as amended, provides for a total credit facility commitment consisting of a $18,000,000 revolving line of credit, a term loan balance of approximately $1,742,000 and a capital line of $1,000,000, with advances available through May 4, 2022. As a result of a recent amendment to our credit facility that we entered into with our lender in March 2023, the revolving line of credit was reduced to $12,500,000. The maximum we can borrow under the revolving part of the credit facility is based on a percentage of the amount of our eligible receivables outstanding at any one time reduced by outstanding standby letters of credit and any borrowing reduction that our lender has or may impose from time to time. At December 31, 2022, we had no borrowing under the revolving part of our credit facility and borrowing availability of up to an additional $4,290,000. The borrowing availability of $4,290,000 at December 31, 2022 included a requirement from our lender that we maintain a minimum of $3,000,000 in borrowing availability. As a result of the amendment to our credit facility that we entered into with our lender as discussed above, we are required to continue to maintain a minimum of $3,000,000 in borrowing availability under the revolving credit until the minimum FCCR requirement for the quarter ended June 30, 2023 has been met and certified to our lender. A lack of positive operating results could have material adverse consequences on our ability to operate our business. Our ability to make principal and interest payments, to refinance indebtedness, and borrow under our credit facility will depend on both our and our subsidiaries’ future operating performance and cash flow. Prevailing economic conditions, interest rate levels, and financial, competitive, business, and other factors affect us. Many of these factors are beyond our control, including the impact of COVID-19.

 

Our indebtedness could limit our financial and operating activities, and adversely affect our ability to incur additional debt to fund future needs.

 

As a result of our indebtedness, we could, among other things, be:

 

required to dedicate a substantial portion of our cash flow to the payment of principal and interest, thereby reducing the funds available for operations and future business opportunities;
make it more difficult for us to satisfy our obligations;
limit our ability to borrow additional money if needed for other purposes, including working capital, capital expenditures, debt service requirements, acquisitions and general corporate or other purposes, on satisfactory terms or at all;
limit our ability to adjust to changing economic, business and competitive conditions;
place us at a competitive disadvantage with competitors who may have less indebtedness or greater access to financing;
make us more vulnerable to an increase in interest rates, a downturn in our operating performance or a decline in general economic conditions; and
make us more susceptible to changes in credit ratings, which could impact our ability to obtain financing in the future and increase the cost of such financing.

 

Any of the foregoing could adversely impact our operating results, financial condition, and liquidity. Our ability to continue our operations depends on our ability to generate profitable operations or complete equity or debt financings to increase our capital.

 

13
 

 

We may be unable to utilize loss carryforwards in the future.

 

We have approximately $25,413,000 and $78,400,000 in net operating loss carryforwards for federal and state income tax purposes, respectively and expires in various amounts starting in 2022 if not used against future federal and state income tax liabilities, respectively. Approximately $25,296,000 of our federal net operating loss carryforwards were generated after December 31, 2017 and thus do not expire. Our net loss carryforwards are subject to various limitations. Our ability to use the net loss carryforwards depends on whether we are able to generate sufficient income in the future years. Further, our net loss carryforwards have not been audited or approved by the Internal Revenue Service.

 

Risks Relating to our Common Stock

 

Issuance of substantial amounts of our common stock, par value $0.001 per share (the “Common Stock”) could depress our stock price or dilute the percentage ownership of our Common Stockholders.

 

Any sales of substantial amounts of our Common Stock in the public market could cause an adverse effect on the market price of our Common Stock and could impair our ability to raise capital through the sale of additional equity securities. The issuance of our Common Stock will result in the dilution in the percentage membership interest of our stockholders and the dilution in ownership value. At December 31, 2022, we had 13,324,756 shares of Common Stock outstanding. In addition, at December 31, 2022, we had outstanding options to purchase 1,018,400 shares of our Common Stock at exercise prices ranging from $2.79 to $7.50 per share and an outstanding warrant to purchase 60,000 shares of our Common Stock at exercise price of $3.51 per share. Future sales of the shares issuable could also depress the market price of our Common Stock.

 

We do not intend to pay dividends on our Common Stock in the foreseeable future.

 

Since our inception, we have not paid cash dividends on our Common Stock, and we do not anticipate paying any cash dividends in the foreseeable future. Our credit facility prohibits us from paying cash dividends on our Common Stock without prior approval from our lender.

 

The price of our Common Stock may fluctuate significantly, which may make it difficult for our stockholders to resell our Common Stock when a stockholder wants or at prices a stockholder finds attractive.

 

The price of our Common Stock on the NASDAQ Capital Markets constantly changes. We expect that the market price of our Common Stock will continue to fluctuate. This may make it difficult for our stockholders to resell the Common Stock when a stockholder wants or at prices a stockholder finds attractive.

 

General Risk Factors

 

Loss of certain key personnel could have a material adverse effect on us.

 

Our success depends on the contributions of our key management, environmental and engineering personnel. Our future success depends on our ability to retain and expand our staff of qualified personnel, including environmental specialists and technicians, sales personnel, and engineers. Without qualified personnel, we may incur delays in rendering our services or be unable to render certain services. We cannot be certain that we will be successful in our efforts to attract and retain qualified personnel as their availability is limited (especially in the current labor market environment) due to the demand for hazardous waste management services and the highly competitive nature of the hazardous waste management industry. We do not maintain key person insurance on any of our employees, officers, or directors.

 

We may not be successful in winning new business mandates from our government and commercial customers or international customers.

 

We must be successful in winning mandates from our government, commercial customers and international customers to replace revenues from projects that we have completed or that are nearing completion and to increase our revenues. Our business and operating results can be adversely affected by the size and timing of a single material contract.

 

Our failure to maintain our safety record could have an adverse effect on our business.

 

Our safety record is critical to our reputation. In addition, many of our government and commercial customers require that we maintain certain specified safety record guidelines to be eligible to bid for contracts with these customers. Furthermore, contract terms may provide for automatic termination in the event that our safety record fails to adhere to agreed-upon guidelines during performance of the contract. As a result, our failure to maintain our safety record could have a material adverse effect on our business, financial condition and results of operations.

 

14
 

 

Systems failures, interruptions or breaches of security and other cyber security risks could have an adverse effect on our financial condition and results of operations.

 

We are subject to certain operational risks to our information systems. Because of efforts on the part of computer hackers and cyberterrorists to breach data security of companies, we face risk associated with potential failures to adequately protect critical corporate, customer and employee data. As part of our business, we develop and retain confidential data about us and our customers, including the U.S. government. We also rely on the services of a variety of vendors to meet our data processing and communications needs.

 

Despite our implemented security measures and established policies, we cannot be certain that all of our systems are entirely free from vulnerability to attack or other technological difficulties or failures or failures on the part of our employees to follow our established security measures and policies. Information security risks have increased significantly. Our technologies, systems, and networks may become the target of cyber-attacks, computer viruses, malicious code, or information security breaches that could result in the unauthorized release, gathering, monitoring, misuse, loss or destruction of our or our customers’ confidential, proprietary and other information and the disruption of our business operations. A security breach could adversely impact our customer relationships, reputation and operation and result in violations of applicable privacy and other laws, financial loss to us or to our customers or to our employees, and litigation exposure. While we maintain a system of internal controls and procedures, any breach, attack, or failure as discussed above could have a material adverse impact on our business, financial condition, and results of operations or liquidity.

 

There is also an increasing attention on the importance of cybersecurity relating to infrastructure. This creates the potential for future developments in regulations relating to cybersecurity that may adversely impact us, our customers and how we offer our services to our customers.

 

We may be exposed to certain regulatory and financial risks related to climate change.

 

Climate change is receiving ever increasing attention from scientists, legislators and the public. The debate is ongoing as to the extent to which our climate is changing, the potential causes of this change and its potential impacts. Some attribute global warming to increased levels of greenhouse gases, including carbon dioxide, which has led to significant legislative and regulatory efforts to limit greenhouse gas emissions. Presently there are no federally mandated greenhouse gas reduction requirements in the United States. However, there are a number of legislative and regulatory proposals to address greenhouse gas emissions, which are in various phases of discussion or implementation. The outcome of federal and state actions to address global climate change could result in a variety of regulatory programs including potential new regulations. Any adoption by federal or state governments mandating a substantial reduction in greenhouse gas emissions could increase costs associated with our operations. Until the timing, scope and extent of any future regulation becomes known, we cannot predict the effect on our financial position, operating results and cash flows.

 

We believe our proprietary technology is important to us.

 

We believe that it is important that we maintain our proprietary technologies. There can be no assurance that the steps taken by us to protect our proprietary technologies will be adequate to prevent misappropriation of these technologies by third parties. Misappropriation of our proprietary technology could have an adverse effect on our operations and financial condition. Changes to current environmental laws and regulations also could limit the use of our proprietary technology.

 

Failure to maintain effective internal control over financial reporting or failure to remediate a material weakness in internal control over financial reporting could have a material adverse effect on our business, operating results, and stock price.

 

Maintaining effective internal control over financial reporting is necessary for us to produce reliable financial reports and is important in helping to prevent financial fraud. If we are unable to maintain adequate internal controls, our business and operating results could be harmed. We are required to satisfy the requirements of Section 404 of Sarbanes Oxley and the related rules of the Commission, which require, among other things, management to assess annually the effectiveness of our internal control over financial reporting. For the year ended December 31, 2021, management concluded that a material weakness existed in internal control over financial reporting related to our application of ASC 606, “Revenue from Contracts with Customers,” specifically to contracts that contain nonstandard terms and conditions. This material weakness has been remediated (see “Item 9A. Controls and Procedures” for a discussion of this material weakness and the remediation plan that were implemented). If we are unable to maintain adequate internal control over financial reporting at any time going forward, there is a reasonable possibility that a misstatement of our annual or interim financial statements will not be prevented or detected in a timely manner. If we cannot produce reliable financial reports, investors could lose confidence in our reported financial information, the market price of our common stock could decline significantly, and our business, financial condition, and reputation could be harmed.

 

15
 

 

Delaware law, certain of our charter provisions, our stock option plans, outstanding warrants and our Preferred Stock may inhibit a change of control under circumstances that could give you an opportunity to realize a premium over prevailing market prices.

 

We are a Delaware corporation governed, in part, by the provisions of Section 203 of the General Corporation Law of Delaware, an anti-takeover law. In general, Section 203 prohibits a Delaware public corporation from engaging in a “business combination” with an “interested stockholder” for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner. As a result of Section 203, potential acquirers may be discouraged from attempting to effect acquisition transactions with us, thereby possibly depriving our security holders of certain opportunities to sell, or otherwise dispose of, such securities at above-market prices pursuant to such transactions. Further, certain of our option plans provide for the immediate acceleration of, and removal of restrictions from, options and other awards under such plans upon a “change of control” (as defined in the respective plans). Such provisions may also have the result of discouraging acquisition of us.

 

We have authorized and unissued 15,589,202 (which include shares issuable under outstanding options to purchase 1,018,400 shares of our Common Stock and shares issuable under an outstanding warrant to purchase 60,000 shares of our Common Stock) shares of our Common Stock and 2,000,000 shares of our Preferred Stock as of December 31, 2022. These unissued shares could be used by our management to make it more difficult for, and thereby discourage, an attempt to acquire control of us.

 

Third party expectations relating to ESG factors may impose additional costs and expose us and our clients to new risks.

 

There is an increasing focus from certain investors and certain of our customers, and other stakeholders concerning corporate responsibility, specifically related to ESG factors. Some investors may use these factors to guide their investment strategies and, in some cases, may choose not to invest in us, or otherwise do business with us, if they believe our policies relating to corporate responsibility are inadequate or do not align with theirs. Third party providers of corporate responsibility ratings and reports on companies have increased in number, resulting in varied standards. In addition, the criteria by which companies’ corporate responsibility practices are assessed are evolving, which could result in greater expectations of us and cause us to undertake costly initiatives to satisfy such new criteria. Alternatively, if we elect not to or are unable to satisfy such new criteria or do not meet the criteria of a specific third-party provider, some investors may conclude that our policies with respect to corporate responsibility are inadequate. We may face reputational damage in the event that our corporate responsibility procedures or standards do not meet the standards set by various constituencies. If we fail to satisfy the expectations of investors, our customers and other stakeholders or our initiatives are not executed as planned, our reputation and financial results could be adversely affected and our revenues, results of operations and ability to grow our business may be negatively impacted. Additionally, new legislative or regulatory initiatives related to ESG could adversely affect our business.

 

ITEM 1B. UNRESOLVED STAFF COMMENTS

 

Not Applicable.

 

16
 

 

ITEM 2. PROPERTIES

 

Our principal executive office is in Atlanta, Georgia. Our Business Center is located in Oak Ridge, Tennessee. Our Treatment Segment facilities are located in Gainesville, Florida; Kingston, Tennessee; Richland, Washington; and Oak Ridge, Tennessee. All of the properties where these facilities operate on are pledged to our senior lender as collateral for our credit facility with the exception of the property at Oak Ridge, Tennessee which is leased. Our Services Segment maintains offices, which are all leased properties. We maintain properties in Valdosta, Georgia and Memphis, Tennessee, which are all non-operational and are included within our discontinued operations.

 

The Company currently leases properties in the following locations for operations and administrative functions within our Treatment and Services Segments, including our corporate office and Business Center:

 

    Square Footage (SF)/    
Location   Acreage (AC)   Expiration of Lease
Oak Ridge, TN (Business Center)   16,319 SF   April 30, 2026
Oak Ridge, TN (Services)   5,000 SF   September 30, 2023
Blaydon On Tyne, England (Services)   1,000 SF   Monthly
New Brighton, PA (Services)   3,558 SF   June 30, 2024
Newport, KY (Services)   1,566 SF   Monthly
Atlanta, GA (Corporate)   6,499 SF   July 31, 2024
Oak Ridge, TN (Treatment)   8.7 AC, including 17,400 SF   September 30, 2023

 

We believe that the above facilities currently provide adequate capacity for our operations and that additional facilities are readily available in the regions in which we operate, which could support and supplement our existing facilities.

 

ITEM 3. LEGAL PROCEEDINGS

 

See “Part II – Item 8 - Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Note 16 – Commitments and Contingencies – Legal Matters” for a discussion of our legal proceedings.

 

ITEM 4. MINE SAFETY DISCLOSURE

 

Not Applicable.

 

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

 

Our Common Stock is traded on the NASDAQ Capital Markets (“NASDAQ”) under the symbol “PESI.” The following table sets forth the high and low market trade prices quoted for the Common Stock during the periods shown. The source of such quotations and information is the NASDAQ online trading history reports.

 

   2022   2021 
   Low   High   Low   High 
Common Stock  1st Quarter  $4.89   $6.52   $5.74   $7.99 
   2nd Quarter   4.91    6.09    6.70    7.95 
   3rd Quarter   4.26    5.93    5.53    7.56 
   4th Quarter   3.20    4.57    6.00    7.30 

 

At February 14, 2023, there were approximately 128 stockholders of record of our Common Stock. The actual number of our stockholders is greater than this number, and includes beneficial owners whose shares are held in “street name” by banks, brokers, and other nominees.

 

17
 

 

Since our inception, we have not paid any cash dividends on our Common Stock and have no dividend policy. Our loan agreement dated May 8, 2020, as amended, prohibits us from paying any cash dividends on our Common Stock without prior approval from our lender. We do not anticipate paying cash dividends on our outstanding Common Stock in the foreseeable future.

 

There were no purchases made by us or on behalf of us or any of our affiliated members of shares of our Common Stock during 2022.

 

See “Note 6 - Capital Stock, Stock Plans, Warrants, and Stock Based Compensation” in Part II, Item 8, “Financial Statements and Supplementary Data” and “Equity Compensation Plans” in Part III, Item 12, “Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matter” for securities authorized for issuance under equity compensation plans which are incorporated herein by reference.

 

ITEM 6.

SELECTED FINANCIAL DATA

 

Not required under Regulation S-K for smaller reporting companies.

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Certain statements contained within this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” (“MD&A”) may be deemed “forward-looking statements” within the meaning of Section 27A of the Act, and Section 21E of the Securities Exchange Act of 1934, as amended (collectively, the “Private Securities Litigation Reform Act of 1995”). See “Special Note regarding Forward-Looking Statements” contained in this report.

 

Management’s discussion and analysis is based, among other things, our audited consolidated financial statements and includes our accounts, the accounts of our wholly-owned subsidiaries and the account of a variable interest entity for which we were the primary beneficiary.

 

The following discussion and analysis should be read in conjunction with our consolidated financial statements and the notes thereto included in Item 8 of this report.

 

COVID-19 and Other Impacts

 

Our 2022 financial results continued to be impacted by COVID-19, among other things. Our Treatment Segment began to see steady improvements in waste receipts starting in the second quarter of 2022 from certain customers who had previously delayed waste shipments due, in part, from the impact of COVID-19 which is reflective of our Treatment Segment’s backlog of approximately $9,156,000 at December 31, 2022, an increase of approximately $2,027,000 from the balance of $7,129,000 at December 31, 2021. This positive trend was negatively impacted by occurrences of severe weather conditions which contributed to temporary delays in waste shipments from certain customers and a temporary shortage in skilled production personnel which peaked through the fourth quarter of 2022 at one of our facilities. In early part of 2022, our Services Segment continued to experience delays/curtailments in project work by certain customers since the award of projects to us late in the second quarter of 2021 due to COVID-19 impact and/or administrative delays. However, starting in the second quarter of 2022, work under these projects had resumed/increased as the pandemic impacts began to subside and has since reached full operational status.

 

In 2022, we continued to realize delays in procurement and planning on behalf of our government clients that saw easing through the second half of the year. Heading into 2023, we expect to see continued improvements in waste receipts and continued increases in project work from contracts recently won and bids submitted in both segments that are awaiting awards, subject to potential impact of COVID-19 and economic impacts.

 

18
 

 

Liquidity Overview

 

We believe we have sufficient liquidity on hand to continue business operations during the next twelve months. At December 31, 2022, we had borrowing availability under our revolving credit facility of approximately $4,290,000 which was based on a percentage of eligible receivables and subject to certain reserves. Our borrowing availability of $4,290,000 at December 31, 2022 included a requirement from our lender that we maintain a minimum of $3,000,000 in borrowing availability. As a result of an amendment to our Loan Agreement that we entered into with our lender in March 2023, we are required to continue to maintain a minimum of $3,000,000 in borrowing availability under our revolving credit until the minimum FCCR requirement for the quarter ended June 30, 2023 has been met and certified to our lender (see “Financing Activities” within this MD&A for a discussion of this amendment). We continue to assess ways to improve our liquidity and the need in reducing operating costs during this volatile time. Reducing operating costs may include curtailing certain capital expenditures and eliminating non-essential expenditures. We continue to closely monitor any potential impact from the countries’ economic conditions and COVID-19 pandemic on all aspects of our business.

 

Although we believe we have sufficient liquidity to support our operations over the next twelve months, due to losses incurred in 2022 and our lender requiring us to maintain a minimum borrowing availability of $3,000,000 as discussed above, we are working toward improving our liquidity by either amending our existing lines of credit, obtaining new term loans or entering into equity transactions. There are no assurances that we will be successful in increasing our liquidity through these efforts.

 

Review

 

Revenue decreased by $1,592,000 or 2.2% to $70,599,000 for the twelve-month ended December 31, 2022 from $72,191,000 for the corresponding period of 2021. The decrease was entirely within our Services Segment where revenue decreased by $1,958,000 or 5.0% to $37,241,000 from $39,199,000. As previously disclosed, work under certain of the new projects awarded to our Services Segment at the end of the second quarter of 2021 continued to be delayed/curtailed into most of the first quarter of 2022 due to COVID-19 impact and/or administrative delays experienced by certain customers. However, work under these projects resumed/increased starting in the second quarter of 2022 and has since reached full operational status. The lower revenue in 2022 was further exacerbated by the completion of a large project in the second quarter of 2021 which was not replaced with a similar size contract because of delays in contract awards and procurement from COVID-19 impact which continued into the first half of 2022 and eased through the second half of 2022. Our Treatment Segment revenue increased by $366,000 or 1.1% primarily due to overall higher waste volume which was offset by lower averaged price waste due to revenue mix. As disclosed above, our Treatment Segment began to see steady improvements in waste receipts starting in the second quarter of 2022 from certain customers who had previously delayed waste shipments due, in part, from the impact of COVID-19. This positive trend was negatively impacted by occurrences of severe weather conditions which resulted in temporary delays in waste shipments from certain customers and a temporary shortage in skilled production personnel which peaked through the fourth quarter of 2022 at one of our facilities.

 

Overall gross profit for 2022 increased $2,785,000 or 40.8%. The increase was entirely from our Services Segment due to higher margin projects. The decrease in Treatment Segment gross profit was impacted by overall lower averaged price waste from revenue mix and the impact of the increase in fixed costs. SG&A expenses increased by approximately $1,807,000 or 14.1% for the year ended December 31, 2022 as compared to the corresponding period of 2021.

 

During the third quarter of 2022, we recorded approximately $1,975,000 in other income and other receivables (within current assets in our Consolidated Balance Sheets), which represent an employee retention credit that we are eligible for under the Coronavirus Aid, Relief, and Economic Security Act, as amended (the “CARES Act”) as result of the COVID-19 pandemic (see “Employee Retention Credit (“ERC”)” within this MD&A for a discussion of this refund that we are expecting resulting from this tax credit).

 

19
 

 

Business Environment

 

Our Treatment and Services Segments’ business continues to be heavily dependent on services that we provide to governmental clients, primarily as subcontractors for others who are prime contractors to government entities or directly as the prime contractor. We believe demand for our services will continue to be subject to fluctuations due to a variety of factors beyond our control, including, without limitation, the economic conditions, the manner in which the applicable government will be required to spend funding to remediate various sites, and/or potential further impact from COVID-19. In addition, our governmental contracts and subcontracts relating to activities at governmental sites in the United States are generally subject to termination for convenience at any time at the government’s option, and our governmental contracts/TOAs with the Canadian government authorities also allow the authorities to terminate the contract/task orders at any time for convenience. Work under all of our contracts/TOAs with Canadian government authorities has substantially been completed. A significant account receivable due to PF Canada is subject to continuing negotiations. See “Known Trends and Uncertainties – Perma-Fix Canada, Inc. (“PF Canada”)” within this MD&A for additional discussion as to a terminated Canadian TOA. Significant reductions in the level of governmental funding or specifically mandated levels for different programs that are important to our business could have a material adverse impact on our business, financial position, results of operations and cash flows.

 

We are continually reviewing methods to raise additional capital to supplement our liquidity requirements, when needed, and reducing our operating costs. We continue to aggressively bid on various contracts, including potential contracts within the international markets.

 

Results of Operations

 

The reporting of financial results and pertinent discussions are tailored to our two reportable segments: The Treatment Segment (“Treatment”) and the Services Segment (“Services”). Our financial results for 2021 also included our Medical Segments. As previously disclosed, we made the strategic decision to cease all R&D activities under the Medical Segment and sold 100% of our interest in Perma-Fix Medical S.A. (“PFM Poland” - which comprised the Medical Segment) in December 2021. Our Medical Segment had not generated any revenue and was involved in our medical isotope production technology. All costs previously incurred by the Medical Segment were included within R&D.

 

Summary - Years Ended December 31, 2022 and 2021

 

Below are the results of continuing operations for years ended December 31, 2022 and 2021 (amounts in thousands):

 

(Consolidated)  2022   %   2021   % 
Net revenues  $70,599    100.0   $72,191    100.0 
Cost of goods sold   60,990    86.4    65,367    90.5 
Gross profit   9,609    13.6    6,824    9.5 
Selling, general and administrative   14,652    20.8    12,845    17.8 
Research and development   336    .4    746    1.0 
Loss on disposal of property and equipment   18        2     
Loss from operations   (5,397)   (7.6)   (6,769)   (9.3)
Interest income   99    .1    26     — 
Interest expense   (175)   (.3)   (247)   (.3)
Interest expense – financing fees   (61)   (.1)   (41)   (.1)
Other income (expense)   1,945    2.8    (86)   (.1)
Gain on extinguishment of debt           5,381    7.4 
Loss on deconsolidation of subsidiary           (1,062)   (1.5)
Loss from continuing operations before taxes   (3,589)   (5.1)   (2,798)   (3.9)
Income tax benefit   (378)   (.6)   (3,890)   (5.4)
(Loss) income from continuing operations  $(3,211)   (4.5)  $1,092    1.5 

 

20
 

 

Revenue

 

Consolidated revenues decreased $1,592,000 for the year ended December 31, 2022 compared to the year ended December 31, 2021, as follows:

 

(In thousands)  2022   % Revenue   2021   % Revenue   Change   % Change 
Treatment                              
Government waste  $21,946    31.1   $20,816    28.8   $1,130    5.4 
Hazardous/non-hazardous (1)   5,062    7.1    4,915    6.8    147    3.0 
Other nuclear waste   6,350    9.0    7,261    10.1    (911)   (12.5)
Total   33,358    47.2    32,992    45.7    366    1.1 
                               
Services                              
Nuclear   35,952    50.9    37,834    52.4    (1,882)   (5.0)
Technical   1,289    1.9    1,365    1.9    (76)   (5.6)
Total   37,241    52.8    39,199    54.3    (1,958)   (5.0)
                               
Total  $70,599    100.0   $72,191    100.0   $(1,592)   (2.2)

 

1) Includes wastes generated by government clients of $2,380,000 and $2,299,000 for the twelve months ended December 31, 2022 and 2021, respectively.

 

Treatment Segment revenue increased by $366,000 or 1.1% for the twelve months ended December 31, 2022 over the same period in 2021. The overall increase was primarily due to higher waste volume as certain customers who had previously delayed waste shipments due to COVID-19 resumed steady waste shipments starting in the latter part of the second quarter. This positive trend was negatively impacted by occurrences of severe weather conditions which resulted in temporary delays in waste shipments from certain customers and a temporary shortage in skilled production personnel which peaked through the fourth quarter of 2022 at one of our facilities. The higher revenue from higher waste volume was offset by lower averaged price waste from revenue mix. Services Segment revenue decreased by approximately $1,958,000 or 5.0%. As previously disclosed, work under certain of the new projects awarded to our Services Segment at the end of the second quarter of 2021 continued to be delayed/curtailed into most of the first quarter of 2022 due to COVID-19 impact and/or administrative delays experienced by certain customers. However, since the second quarter of 2022, work under these projects had resumed/increased and has since reached full operational status. The lower revenue in 2022 was further exacerbated by the completion of a large project in the second quarter of 2021 which was not replaced with a similar size contract because of delays in contract awards and procurement from COVID-19. Our Services Segment revenues are project based; as such, the scope, duration and completion of each project vary. As a result, our Services Segment revenues are subject to differences relating to timing and project value. In 2022, our Segments continued to realize delays in procurement and planning on behalf of our government clients which did not ease until the second half of 2022.

 

Cost of Goods Sold

 

Cost of goods sold decreased $4,377,000 for the year ended December 31, 2022, as compared to the year ended December 31, 2021, as follows:

 

       %       %     
(In thousands)  2022   Revenue   2021   Revenue   Change 
Treatment  $28,115    84.3   $26,274    79.6   $1,841 
Services   32,875    88.3    39,093    99.7    (6,218)
Total  $60,990    86.4   $65,367    90.5   $(4,377)

 

Cost of goods sold for the Treatment Segment increased by approximately $1,841,000 or 7.0%. Treatment Segment’s variable costs increased by approximately $607,000 primarily due to higher material and supplies, transportation, and outside services costs. Treatment Segment’s overall fixed costs were higher by approximately $1,234,000 resulting from the following: general expenses were higher by $483,000 primarily due to higher utility costs; depreciation expenses were higher by approximately $392,000 due to depreciation for asset retirement obligations in connection with our EWOC facility; regulatory expenses were higher by approximately $232,000 primarily due to additional closure costs recorded for our EWOC facility due to change in estimated costs; maintenance costs were higher by approximately $109,000; salaries and payroll related expenses were higher by $61,000; and travel expenses were lower by approximately $43,000. Services Segment cost of goods sold decreased $6,218,000 or 15.9% primarily due to lower revenue. The decrease in cost of goods sold was primarily due to lower salaries/payroll related, outside services, material and supplies and travel costs totaling approximately $6,863,000 which was offset by higher disposal, transportation and general expenses totaling approximately $645,000. Included within cost of goods sold is depreciation and amortization expense of $2,027,000 and $1,654,000 for the twelve months ended December 31, 2022, and 2021, respectively.

 

21
 

 

Gross Profit

 

Gross profit for the year ended December 31, 2022 was $2,785,000 higher than 2021 as follows:

 

       %       %     
(In thousands)  2022   Revenue   2021   Revenue   Change 
Treatment  $5,243    15.7   $6,718    20.4   $(1,475)
Services   4,366    11.7    106    0.3    4,260 
Total  $9,609    13.6   $6,824    9.5   $2,785 

 

Treatment Segment gross profit decreased by $1,475,000 or approximately 22.0% and gross margin decreased to 15.7% from 20.4% primarily due to lower averaged price waste from revenue mix and the impact of the increase in fixed costs. Services Segment gross profit increased by $4,260,000 or 4,018.9% and gross margin increased to 11.7% from 0.3% primarily due to higher margin projects. Our overall Services Segment gross margin is impacted by our current projects which are competitively bid on and will therefore, have varying margin structures.

 

SG&A

 

SG&A expenses increased $1,807,000 for the year ended December 31, 2022 as compared to the corresponding period for 2021 as follows:

 

(In thousands)  2022   % Revenue   2021   % Revenue   Change 
Administrative  $6,882       $5,751       $1,131 
Treatment   4,419    13.2    4,030    12.2    389 
Services   3,351    9.0    3,064    7.8    287 
Total  $14,652    20.8   $12,845    17.8   $1,807 

 

Administrative SG&A expenses were higher primarily due to the following: overall outside services expenses were higher by approximately $654,000 resulting from higher consulting/outside services/audit fees; travel expenses were higher by approximately $19,000; general expenses were higher by approximately $13,000 in various categories; and salaries and payroll related expenses were higher by approximately $445,000 primarily due to higher stock-based compensation expenses from options granted to certain employees in October 2021 and higher 401(k) plan matching expenses as our payroll expenses in 2021 included more forfeitures of 401(k) plan matching funds contributed by us for former employees who failed to meet the 401(k) plan vesting requirements. Additionally, Administrative salaries and payroll related expenses were higher as in 2021, resources were allocated in supporting Medical Segment’s R&D/administrative functions. Treatment Segment SG&A expenses were higher primarily due to the following: outside services expense were higher by $120,000 due to more consulting/business matters (including our ESG initiatives); salaries and payroll related expenses were higher by $46,000; travel expenses were higher by approximately $59,000; and general expenses were higher by $164,000 which included higher tradeshow expenses and various other categories. The increase in SG&A expenses within our Services Segment was primarily due to the following: travel expenses were higher by $32,000; general expenses were higher by approximately $107,000 which included higher tradeshow expenses and various other categories; salaries/payroll related and consulting expenses were higher by approximately $202,000, and credit loss expense on accounts receivable was lower by approximately $54,000. Included in SG&A expenses is depreciation and amortization expense of $82,000 and $33,000 for the twelve months ended December 31, 2022 and 2021, respectively.

 

22
 

 

R&D

 

R&D expenses decreased $410,000 for the year ended December 31, 2022 as compared to the corresponding period of 2021 as follows:

 

(In thousands)  2022   2021   Change 
Administrative  $67   $40   $27 
Treatment   246    221    25 
Services   23    71    (48)
PF Medical       414    (414)
Total  $336   $746   $(410)

 

R&D costs consist primarily of employee salaries and benefits, laboratory costs, third party fees, and other related costs associated with the development of new technologies and technological enhancement of new potential waste treatment processes. The decrease was primarily the result of the sale of PFM Poland in December 2021 which comprised of our Medical Segment and which previously was involved in the R&D of our medical isotope technology.

 

Interest Income

 

Interest income increased by approximately $73,000 for the twelve months ended December 31 2022 as compared to the corresponding period of 2021 primarily due to higher interest earned from our finite risk sinking fund.

 

Interest Expense

 

Interest expense decreased by approximately $72,000 for the twelve months ended December 31, 2022 as compared to the corresponding period of 2021 primarily due to lower interest expense from our declining term loan balance outstanding. Also, interest expense for the first six months of 2021 included interest accrued for our Paycheck Protection Program (“PPP”) Loan which was forgiven by the U.S. Small Business Administration (“SBA”) effective June 15, 2021. The overall lower interest expense was offset by monthly interest incurred starting in June of 2022 from the capital line under our credit facility.

 

Income Taxes

 

We had income tax benefits of $378,000 and $3,890,000 for continuing operations for the twelve months ended December 31, 2022 and 2021, respectively. Our effective tax rates were approximately 10.5% and 139.0% for the twelve months ended December 31, 2022 and 2021, respectively. Our effective tax rates for the twelve months ended December 31, 2022 were impacted by non-deductible expenses and state taxes. Our effective tax rate for the twelve months ended December 31, 2021 was substantially impacted by the release of our valuation allowance on deferred tax assets primarily related to U.S. Federal income taxes during the third quarter of 2021 of approximately $2,351,000. For the twelve months ended December 31, 2021, the primary reasons for the differences between our effective tax rate and statutory tax rate were due to the release of valuation allowance and the forgiveness of our PPP Loan which was included in our Consolidated Statement of Operations as “Gain on extinguishment of debt” but is exempt from income taxes.

 

Backlog

 

Our Treatment Segment maintains a backlog of stored waste, which represents waste that has not been processed. The backlog is principally a result of the timing and complexity of the waste being brought into the facilities and the selling price per container. At December 31, 2022, our Treatment Segment had a backlog of approximately $9,156,000, as compared to approximately $7,129,000 at December 31, 2021. Additionally, the time it takes to process waste from the time it arrives may increase due to the types and complexities of the waste we are currently receiving. We typically process our backlog during periods of low waste receipts, which historically has been in the first or fourth quarters.

 

23
 

 

Discontinued Operations and Environmental Contingencies

 

Our discontinued operations consist of all our subsidiaries included in our Industrial Segment which encompasses subsidiaries divested in 2011 and prior and three previously closed locations.

 

Our discontinued operations had no revenue for the twelve months ended December 31, 2022 and 2021. We incurred net losses of $605,000 (net of tax benefit of $199,000) and $421,000 (net of tax benefit of $139,000) for our discontinued operations for the twelve months ended December 31, 2022 and 2021, respectively. The increase in net losses in 2022 as compared to 2021 was primarily due to costs incurred in connection with management of administrative and regulatory matters within our discontinued operations. We have three environmental remediation projects, all within our discontinued operations, which principally entail the removal/remediation of contaminated soil, and, in most cases, the remediation of surrounding ground water.

 

Liquidity and Capital Resources

 

Our cash flow requirements during the twelve months ended December 31, 2022 were primarily financed by our operations, cash on hand and credit facility availability. Subject to COVID-19 and other impacts as discussed above, our cash flow requirements for the next twelve months will consist primarily of general working capital needs, scheduled principal payments on our debt obligations, remediation projects, and planned capital expenditures. We plan to fund these requirements from our operations, credit facility availability, cash on hand and a refund that we expect to receive under the ERC program under the CARES Act (see a discussion of this expected refund below – “Employee Retention Credit (“ERC”)”). We continue to explore all sources of increasing our capital and/or liquidity and to improve our revenue and working capital (see our discussion contained in this “MD&A – Liquidity Overview” above for further discussion as to liquidity. We are continually reviewing operating costs and reviewing the possibility of further reducing operating costs and non-essential expenditures to bring them in line with revenue levels, when necessary. At this time, we believe that our cash flows from operations, our available liquidity from our credit facility, our cash on hand and the expected refund from the ERC program should be sufficient to fund our operations for the next twelve months. However, due to the uncertainty of the countries’ current economic environment and the COVID-19 as disclosed in “COVID-19 and Other Impacts” within this MD&A, there are no assurances such will be the case.

 

The following table reflects the cash flow activity for the year ended December 31, 2022 and the corresponding period of 2021:

 

(In thousands)  2022   2021 
Cash provided by (used in) operating activities of continuing operations  $164   $(6,316)
Cash used in operating activities of discontinued operations   (717)   (521)
Cash used in investing activities of continuing operations   (997)   (1,564)
Cash (used in) provided by financing activities of continuing operations   (921)   4,943 
Effect of exchange rate changes on cash   (4)   (1)
Decrease in cash and finite risk sinking fund (restricted cash)  $(2,475)  $(3,459)

 

At December 31, 2022, we were in a positive cash position with no revolving credit balance. At December 31, 2022, we had cash on hand of approximately $1,866,000.

 

Operating Activities

 

Accounts receivable, net of credit losses, totaled $9,364,000 at December 31, 2022, a decrease of $2,008,000 from the December 31, 2021 balance of $11,372,000. The decrease was attributed to timing of invoicing and accounts receivable collection. Our contracts with our customers are subject to various payment terms and conditions. Additionally, our contracts with our customers may sometimes result in modifications which can cause delays in collections. Our accounts receivable at December 31, 2022 include invoices for work performed which previously was in our unbilled account for a certain Canadian project that remain outstanding and subject to negotiations (see unbilled receivables discussion below). See discussion under “Known Trends and Uncertainties – Perma-Fix Canada, Inc. (“PF Canada”)” for a discussion as to this certain account receivable.

 

24
 

 

Unbilled receivables totaled $6,062,000 at December 31, 2022, a decrease of $2,933,000 from the December 31, 2021 balance of $8,995,000. The decrease in unbilled receivables was primarily within our Services Segment due to invoicing in connection with our Canadian projects.

 

Accounts payable, totaled $10,325,000 at December 31, 2022, a decrease of $1,650,000 from the December 31, 2021 balance of $11,975,000. Our accounts payable are impacted by the timing of payments as we are continually managing payment terms with our vendors to maximize our cash position throughout all segments.

 

We had working capital of $818,000 (which included working capital of our discontinued operations) at December 31, 2022, as compared to working capital of $4,060,000 at December 31, 2021. Our working capital was negatively impacted primarily by our results of operations which were heavily impacted from COVID-19 and other delays as discussed previously, especially in the first quarter of 2022. Our working capital was positively impacted by the employee retention credit in the amount of approximately $1,975,000 recorded as current receivables (within “Prepaid and other assets” on our Consolidated Balance Sheets. See a discussion of this credit below “Employee Retention Credit (“ERC”)”).

 

Investing Activities

 

During 2022, our purchases of capital equipment totaled approximately $1,137,000, of which $114,000 was subject to financing, with the remaining funded from cash from operations and our credit facility. We have budgeted approximately $2,000,000 for 2023 capital expenditures primarily for our Treatment and Services Segments to maintain operations and regulatory compliance requirements and support revenue growth. Certain of these budgeted projects may either be delayed until later years or deferred altogether. We plan to fund our capital expenditures from cash from operations and/or financing. The initiation and timing of projects are also determined by financing alternatives or funds available for such capital projects.

 

During March 2022, we signed a joint venture term sheet addressing plans to partner with Springfields Fuels Limited (“SFL”), an affiliate of Westinghouse Electric Company LLC, to develop and manage a nuclear waste-materials treatment facility (the “Facility”) in the United Kingdom. The Facility is for the purpose of expanding the partners’ waste treatment capabilities for the European nuclear market. It is expected that upon finalization of a partnership agreement, SFL will have an ownership interest of fifty-five (55) percent and our interest will be forty-five (45) percent. The finalization, form and capitalization of this unpopulated partnership is subject to numerous conditions, including but not limited to, winning a certain contract, completion and execution of a definitive agreement and facility design, granting of required regulatory, lender or permitting approvals and updated cost and profitability analysis based on current and forecast future economic conditions. Upon finalization of this venture, we will be required to make an investment in this venture. The amount of our investment, the period of which it is to be made and the method of funding are to be determined.

 

Financing Activities

 

We entered into a Second Amended and Restated Revolving Credit, Term Loan and Security Agreement, dated May 8, 2020, (the “Loan Agreement”), with PNC National Association (“PNC”), acting as agent and lender. The Loan Agreement provides us with the following credit facility with a maturity date of March 15, 2024: (a) up to $18,000,000 revolving credit (“revolving credit”) (see discussion below as to an amendment dated March 21, 2023 which reduced the revolving credit to $12,500,000) and (b) a term loan (“term loan”) of approximately $1,742,000, requiring monthly installments of $35,547. The maximum that we can borrow under the revolving credit is based on a percentage of eligible receivables (as defined) at any one time reduced by outstanding standby letters of credit and borrowing reductions that our lender may impose from time to time. Our Loan Agreement, as amended (the “Amended Loan Agreement”), also provides a capital expenditure line of up to $1,000,000 with advances on the line, subject to certain limitations, permitted for up to twelve months starting May 4, 2021 (the “Borrowing Period”). Only interest is payable on advances during the Borrowing Period. At the end of the Borrowing Period, the total amount advanced under the line will amortize equally based on a five-year amortization schedule with principal payment due monthly plus interest. At the maturity date of the Amended Loan Agreement, any unpaid principal balance plus interest, if any, will become due. At the end of the Borrowing Period, advance on the capital line totaled approximately $524,000. We are required to make monthly principal installment payment of approximately $8,700 starting June 1, 2022 plus interest. At December 31, 2022, balance on the capital line was approximately $463,000. The advance made on the capital line was used to purchase the underlying asset under a previous finance lease.

 

25
 

 

During 2022, we entered into further amendments to our Amended Loan Agreement with our lender, which provided the following, among other things (with the amended terms set forth in a Revised Loan Agreement):

 

waived our failure to meet the minimum quarterly fixed charge coverage ratio (“FCCR”) requirement for the fourth quarter of 2021 and second quarter of 2022;
removed the quarterly FCCR testing requirement for the first and third quarters of 2022;
reinstated the quarterly FCCR testing requirement starting for the fourth quarter of 2022 and revised the methodology in calculating the FCCR for the quarter ended December 31, 2022 and the methodology to be used in calculating the FCCR for the quarter ending March 31, 2023 (with no change to the minimum 1.15:1 ratio requirement for each quarter);
required maintenance of a minimum of $3,000,000 in borrowing availability under the revolving credit until the minimum FCCR requirement for the quarter ended December 31, 2022 has been met and certified to the lender;
revised the annual rate used to calculate the Facility Fee (as defined in the Loan Agreement) on the revolving credit, with addition of the capital expenditure line, from 0.375% to 0.500%. Upon meeting the minimum FCCR requirement of 1.15:1 on a twelve-month trailing basis, the Facility Fee rate of 0.375% will be reinstated;
added certain additional anti-terrorism provisions to the covenants; and
replaced the London InterBank Offer Rate (“LIBOR”) based interest rate benchmark with the Secured Overnight Finance Rate (“SOFR”). As a result of this new provision, payment of annual rate of interest due on the revolving credit is at prime (7.50% at December 31, 2022) plus 2% or Term SOFR Rate (as defined in the Revised Loan Agreement) plus 3.00% plus an SOFR Adjustment applicable for an interest period selected by us and payment of annual rate of interest due on the term loan and the capital expenditure line is at prime plus 2.50% or Term SOFR Rate plus 3.50% plus an SOFR Adjustment applicable for an interest period selected by us. A SOFR Adjustment rates of 0.10% and 0.15% are applicable for a one-month interest period and three-month period, respectively, that may be selected by us

 

In connection with the amendments, we paid our lender fees totaling $30,000 which is being amortized over the remaining term of the Revised Loan Agreement as interest expense-financing fees.

 

Our credit facility under our Revised Loan Agreement with PNC contains certain financial covenants, along with customary representations and warranties. A breach of any of these financial covenants, unless waived by PNC, could result in a default under our credit facility allowing our lender to immediately require the repayment of all outstanding debt under our credit facility and terminate all commitments to extend further credit. We were not required to perform testing of the FCCR requirement in the first and third quarters of 2022 pursuant to the amendments that we entered with our lender in 2022 as discussed above. Based on an amendment that we entered into with our lender on March 21, 2023 as discussed below, we were not required to perform testing of the FCCR requirement in the fourth quarter of 2022. We failed to meet our FCCR requirement in the second quarter of 2022; however, this non-compliance was waived by our lender pursuant to an amendment that we entered into with our lender in 2022 as discussed above. Other than the above discussion pertaining to our FCCR requirements, we met all of our other financial covenant requirements in each of the quarters of 2022. We expect to meet our quarterly financial covenant requirements for the next twelve months under our Amended Loan Agreement.

 

On March 21, 2023, we entered into an amendment to our Revised Loan Agreement with our lender which provides, among other things, the following:

 

removed the quarterly FCCR testing requirement for the fourth quarter of 2022 and removes the FCCR testing requirement the first quarter of 2023;

 

26
 

 

reduced the maximum revolving credit line under the credit facility from $18,000,000 to $12,500,000;
reinstates the quarterly FCCR testing requirement starting in the second quarter of 2023 using a trailing twelve months period (with no change to the minimum 1.15:1 ratio requirement for each quarter); and
requires maintenance of a minimum of $3,000,000 in borrowing availability under the revolving credit until the minimum FCCR requirement for the quarter ended June 30, 2023 has been met and certified to the lender.

 

In connection with the amendment, the Company paid its lender a fee of $25,000.

 

From this point on, we may terminate our Revised Loan Agreement upon 90 days’ prior written notice upon payment in full of our obligations under the Revised Loan Agreement with no early termination fees.

 

Employee Retention Credit (“ERC”)

 

The CARES Act, which was enacted on March 27, 2020, provides an ERC for qualifying businesses keeping employees on their payroll during the COVID-19 pandemic. The ERC was subsequently amended by the Taxpayer Certainty and Disaster Tax Relief Act of 2020, the Consolidated Appropriation Act of 2021, and the American Rescue Plan Act of 2021, all of which amended and extended the ERC availability and guidelines under the CARES Act. Following these amendments, we determined that we were eligible for the ERC, and as a result of the foregoing legislations, are eligible to claim a refundable tax credit against our share of certain payroll taxes equal to 70% of the qualified wages paid to employees between July 1, 2021 and September 30, 2021. Qualified wages are limited to $10,000 per employee per calendar quarter in 2021 for a maximum allowable ERC per employee of $7,000 per calendar quarter in 2021. For purposes of the amended ERC, an eligible employer is defined as having experienced a significant (20% or more) decline in gross receipts during one or more of the first three 2021 calendar quarters when compared to 2019.

 

During the third quarter of 2022, we determined we were eligible for the ERC and amended our third quarter 2021 employer payroll tax filings claiming a refund from the U.S. Treasury in the amount of approximately $1,975,000. As there is no authoritative guidance under U.S. GAAP on accounting for government assistance to for-profit business entities, we account for the ERC by analogy to International Accounting Standard (“IAS”) 20, Accounting for Government Grants and Disclosure of Government Assistance. In accordance with IAS 20, management determined it has reasonable assurance for receipt of the ERC and recorded the expected refund as other income (within “Other income (expense)”) on our Consolidated Statements of Operations and other receivables (within “Prepaid and other assets”) on our Consolidated Balance Sheets.

 

Payment of Deferred Employment Tax Deposits

 

The CARES Act provided employers the option to defer the payment of an employer’s share of social security taxes beginning on March 27, 2020 through December 31, 2020, with 50% of the amount of social security taxes deferred to become due on December 31, 2021 with the remaining 50% due on December 31, 2022. Our deferment of such taxes totaled approximately $1,252,000 of which approximately $626,000 was paid in December 2021 with the remaining paid in December 2022 (previously included in “Accrued expenses” within current liabilities in our Consolidated Balance Sheets).

 

Off Balance Sheet Arrangements

 

From time to time, we are required to post standby letters of credit and various bonds to support contractual obligations to customers and other obligations, including facility closures. At December 31, 2022, the total amount of standby letters of credit outstanding totaled approximately $3,016,000 and the total amount of bonds outstanding totaled approximately $35,432,000. We also provide closure and post-closure requirements through a financial assurance policy for certain of our Treatment Segment facilities through American International Group, Inc. (“AIG”). At December 31, 2022, the closure and post-closure requirements for these facilities were approximately $21,175,000.

 

27
 

 

Critical Accounting Policies and Estimates

 

Our consolidated financial statements are prepared based upon the selection and application of US GAAP, which may require us to make estimates, judgments and assumptions that affect amounts reported in our financial statements and accompanying notes. The accounting policies below are those we believe affect the more significant estimates and judgments used in preparation of our financial statements. Our other accounting policies are described in the accompanying notes to our consolidated financial statements of this Form 10-K (see “Item 8 – Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – “Note 2 – Summary of Significant Accounting Policies”):

 

Intangible Assets. Intangible assets consist primarily of the recognized value of the permits required to operate our business. We continually monitor the propriety of the carrying amount of our permits to determine whether current events and circumstances warrant adjustments to the carrying value.

 

Indefinite-lived intangible assets are not amortized but are reviewed for impairment annually as of October 1, or when events or changes in the business environment indicate that the carrying value may be impaired. If the fair value of the asset is less than the carrying amount, we perform a quantitative test to determine the fair value. The impairment loss, if any, is measured as the excess of the carrying value of the asset over its fair value. Significant judgments are inherent in these analyses and include assumptions for, among other factors, forecasted revenue, gross margin, growth rate, operating income, timing of expected future cash flows, and the determination of appropriate long-term discount rates.

 

Impairment testing of our permits related to our Treatment reporting unit as of October 1, 2022 and 2021 resulted in no impairment charges.

 

Intangible assets that have definite useful lives are amortized using the straight-line method over the estimated useful lives (with the exception of customer relationships which are amortized using an accelerated method) and are excluded from our annual intangible asset valuation review as of October 1. Intangible assets with definite useful lives are also tested for impairment whenever events or changes in circumstances indicate that the asset’s carrying value may not be recoverable.

 

Our future cash flow assumptions and conclusions with respect to asset impairments could be impacted by changes arising from (i) a sustained period of economic and industrial slowdowns (ii) inability to scale our operations and implement cost reduction efforts during reduced demand and/or (iii) a significant decline in our share price for a sustained period of time. These factors, among others, could significantly impact the impairment analysis and may result in future asset impairment charges that, if incurred, could have a material adverse effect on our financial condition and results of operations. We believe that the assumptions and estimates utilized for the reporting periods are appropriate based on the information available to management.

 

Accrued Closure Costs and Asset Retirement Obligations (“ARO”). Accrued closure costs represent our estimated environmental liability to clean up our facilities as required by our permits, in the event of closure. ASC 410, “Asset Retirement and Environmental Obligations” requires that the discounted fair value of a liability for an ARO be recognized in the period in which it is incurred with the associated ARO capitalized as part of the carrying cost of the asset. The recognition of an ARO requires that management make numerous estimates, assumptions and judgments regarding such factors as estimated probabilities, timing of settlements, material and service costs, current technology, laws and regulations, and credit adjusted risk-free rate to be used. We develop estimates for the cost of these activities based on our evaluation of site-specific facts and circumstances, such as the existence of structures and other improvements that would need to be dismantled and the length of the post-closure period as determined by the applicable regulatory agency, among other things. Included in our cost estimates are our interpretation of current regulatory requirements and any proposed regulatory changes. These cost estimates may change in the future due to various circumstances including, but not limited to, permit modifications, changes in legislation or regulations, technological changes and results of environmental studies. Our cost estimates are calculated using internal sources as well as input from third-party experts. This estimate is inflated, using an inflation rate, to the expected time at which the closure will occur, and then discounted back, using a credit adjusted risk free rate, to the present value. ARO’s are included within buildings as part of property and equipment and are depreciated over the estimated useful life of the property. In periods subsequent to initial measurement of the ARO, we must recognize period-to-period changes in the liability resulting from the passage of time and revisions to either the timing or the amount of the original estimate of undiscounted cash flow. Increases in the ARO liability due to passage of time impact net income as accretion expense and are included in cost of goods sold in the Consolidated Statements of Operations. Changes in the estimated future cash flows costs underlying the obligations (resulting from changes or expansion at the facilities) require adjustment to the ARO liability calculated and are capitalized and charged as depreciation expense, in accordance with our depreciation policy.

 

Income Taxes. The provision for income tax is determined in accordance with ASC 740, “Income Taxes.” As part of the process of preparing our consolidated financial statements, we are required to estimate our income taxes in each of the jurisdictions in which we operate. We record this amount as a provision or benefit for taxes. This process involves estimating our actual current tax exposure, including assessing the risks associated with tax audits, and assessing temporary differences resulting from different treatment of items for tax and accounting purposes. These differences result in deferred tax assets and liabilities.

 

We regularly review deferred  tax assets by jurisdiction to assess their potential realization and establish a valuation allowance for portions of such assets that we believe will not be realized. In performing this review, we make estimates and assumptions regarding projected future taxable income, the expected timing of the reversals of existing temporary differences and the implementation of  tax planning strategies. A change in these assumptions could cause an increase or decrease to the valuation allowance which could materially impact our results of operations. 

 

28
 

 

Recent Accounting Pronouncements

 

See “Item 8 – Financial Statements and Supplementary Data” – Notes to Consolidated Financial Statements” – Note 2 – Summary of Significant Accounting Policies” for the recent accounting pronouncements that have been adopted during the year ended December 31, 2022, or will be adopted in future periods.

 

Known Trends and Uncertainties

 

Economic Conditions. Our business continues to be heavily dependent on services that we provide to governmental clients, primarily as subcontractors for others who are prime contractors to government authorities (particularly the DOE and DOD) or directly as the prime contractor. We believe demand for our services will continue to be subject to fluctuations due to a variety of factors beyond our control, including without limitation, the economic conditions, the manner in which the government entity will be required to spend funding to remediate various sites, and potential COVID-19 impact. In addition, our U.S. governmental contracts and subcontracts relating to activities at governmental sites are generally subject to termination for convenience at any time at the option of the government. Our TOAs with the Canadian government also provided that the government may terminate a TOA at any time for convenience. Significant reductions in the level of governmental funding or specifically mandated levels for different programs that are important to our business could have a material adverse impact on our business, financial position, results of operations and cash flows.

 

Significant Customers. Our Treatment and Services Segments have significant relationships with the U.S governmental authorities through contracts entered into indirectly as subcontractors for others who are prime contractors or directly as the prime contractor to government authorities. We also had significant relationships with Canadian government authorities primarily through TOAs entered into with Canadian government authorities. Project work under TOAs with Canadian government authorities has substantially been completed. Our inability to continue under existing contracts that we have with the U.S government (directly or indirectly as a subcontractor) or significant reductions in the level of governmental funding in any given year could have a material adverse impact on our operations and financial condition.

 

We performed services relating to waste generated by government clients (domestic and foreign (primarily Canadian)), either directly as a prime contractor or indirectly for others as a subcontractor to government entities, representing approximately $60,030,000, or 85.0%, of our total revenue during 2022, as compared to $60,812,000, or 84.2%, of our total revenue during 2021.

 

Our revenues are project/event based where the completion of one contract with a specific customer may be replaced by another contract with a different customer from year to year.

 

Perma-Fix Canada, Inc. (“PF Canada”)

 

During the fourth quarter of 2021, PF Canada received a Notice of Termination (“NOT”) from Canadian Nuclear Laboratories, LTD. (“CNL”) on a Task Order Agreement (“TOA”) that PF Canada entered into with CNL in May 2019 for remediation work within Ontario, Canada (“Agreement”). The NOT was received after work under the TOA was substantially completed and work under the TOA has since been completed. CNL may terminate the TOA at any time for convenience. As of December 31, 2022, PF Canada has approximately $1,853,000 in unpaid receivables due from CNL as a result of work performed under the TOA. Additionally, CNL has approximately $1,060,000 in contractual holdback under the TOA that is payable to PF Canada. CNL also established a bond securing approximately $1,900,000 (CAD) to cover certain issues raised in connection with the TOA. Under the TOA, CNL may be entitled to set off certain costs and expenses incurred by CNL in connection with the termination of the TOA, including the bond as discussed above, against amounts owed to PF Canada for work performed by PF Canada or its subcontractors. PF Canada continues to be in discussions with CNL to finalize the amounts due to PF Canada under the TOA and continues to believe these amounts are due and payable to PF Canada.

 

29
 

 

Supply Chain. We use various commercially available materials and supplies which include among other things chemicals, containers/drums and PPE in our operations. We generally source these items from various suppliers in order to take advantage of competitive pricing.

 

We also utilize various types of equipment, which include among other things trucks, flatbeds, lab equipment, heavy machineries, in carrying out our business operations. Our equipment may be obtained through direct purchase, rental option or leases. Due to some of our specialized waste treatment processes, certain equipment that we utilize are designed and built to our specifications. We rely on various commercial equipment suppliers for the construction of these equipment. Due to supply chain challenges, we previously experienced a delay in the delivery of a new waste processing unit to us by our supplier due to shortage of parts required for the construction of the unit, among other things, This supply chain interruption delayed deployment of our new technology which negatively impacted our revenue for 2021 and the first quarter of 2022 as associated revenue was not able to be generated. Deployment of this unit commenced in mid-May of 2022. Continued increases in pricing and/or potential delays in procurements of material and supplies and equipment required for our operations resulting from further tightening supply chain could further adversely affect our operations and profitability.

 

Inflation and Cost Increases. Continued increases in any of our operating costs, including further changes in fuel prices, wage rates, supplies, and utility costs, may further increase our overall cost of goods sold or operating expenses. Some of these cost increases have been the result of inflationary pressures that could further reduce profitability. We may attempt to increase our sales prices in order to maintain satisfactory margin; however, competitive pressures in our industry may have the effect of inhibiting our ability to reflect these increased costs in the prices of our services that we provide to our customers and therefore reduce our profitability.

 

Liquidity. See above discussion contained herein as to issues relating to “Liqudity” and efforts to improve our liquidity

 

Related Party Transactions

 

See a discussion of the Company’s related party transactions in “Item 8 – Financial Statements and Supplementary Data – Notes to Consolidate Financial Statements – Note 18 – Related Party Transactions and Note 20 – Subsequent Events – Executive Compensation - MIPs.”

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not required under Regulation S-K for smaller reporting companies.

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Forward-looking Statements

 

Certain statements contained within this report may be deemed “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (collectively, the “Private Securities Litigation Reform Act of 1995”). All statements in this report other than a statement of historical fact are forward-looking statements that are subject to known and unknown risks, uncertainties and other factors, which could cause actual results and performance of the Company to differ materially from such statements. The words “believe,” “expect,” “anticipate,” “intend,” “will,” and similar expressions identify forward-looking statements. Forward-looking statements contained herein relate to, among other things,

 

demand for our services;
reductions and improvement in the level of government funding in future years;

 

30
 

 

reducing operating costs and non-essential expenditures;
ability to meet loan agreement quarterly financial covenant requirements;
funding of cash flow requirements;
Canadian receivables;
sufficient liquidity to continue business;
future results of operations and liquidity;
increasing liquidity;
government funding for our services;
may not have liquidity to repay debt if our lender accelerates payment of our borrowings;
manner in which the applicable government will be required to spend funding to remediate various sites;
funding operations;
continued increases in pricing and/or further tightening supply chain;
fund capital expenditures from cash from operations and/or financing;
impact from COVID-19 and economic conditions;
continue improvement in waste receipts and project work;
submitted bid;
ownership percentage interest upon finalization of partnership agreement;
investment requirement upon finalization of joint venture;
positive trends;
compliance with environmental laws, rules and regulations;
potential effect of being a PRP;
potential sites for violations of environmental laws and remediation of our facilities;
ERC refund;
future price increases;
sales prices; and
continuation of contracts with federal government.

 

While the Company believes the expectations reflected in such forward-looking statements are reasonable, it can give no assurance such expectations will prove to be correct. There are a variety of factors, which could cause future outcomes to differ materially from those described in this report, including, but not limited to:

 

general economic conditions;
contract bids, including international markets;
material reduction in revenues;
inability to meet PNC covenant requirements;
inability to collect in a timely manner a material amount of receivables;
increased competitive pressures;
inability to maintain and obtain required permits and approvals to conduct operations;
public not accepting our new technology;
inability to develop new and existing technologies in the conduct of operations;
inability to maintain and obtain closure and operating insurance requirements;
inability to retain or renew certain required permits;
discovery of additional contamination or expanded contamination at any of the sites or facilities leased or owned by us or our subsidiaries which would result in a material increase in remediation expenditures;
delays at our third-party disposal site can extend collection of our receivables greater than twelve months;
refusal of third-party disposal sites to accept our waste;
changes in federal, state and local laws and regulations, especially environmental laws and regulations, or in interpretation of such;
requirements to obtain permits for TSD activities or licensing requirements to handle low level radioactive materials are limited or lessened;

 

31
 

 

potential increases in equipment, maintenance, operating or labor costs;
management retention and development;
financial valuation of intangible assets is substantially more/less than expected;
the requirement to use internally generated funds for purposes not presently anticipated;
inability to continue to be profitable on an annualized basis;
inability of the Company to maintain the listing of its Common Stock on the NASDAQ;
terminations of contracts with government agencies or subcontracts involving government agencies or reduction in amount of waste delivered to the Company under the contracts or subcontracts;
renegotiation of contracts involving government agencies;
federal government’s inability or failure to provide necessary funding to remediate contaminated federal sites;
disposal expense accrual could prove to be inadequate in the event the waste requires re-treatment;
inability to raise capital on commercially reasonable terms;
inability to increase profitable revenue;
impact of the COVID-19 and economic uncertainties;
new governmental regulations;
lender refuses to waive non-compliance or revise our covenant so that we are in compliance;
continued supply chain interruptions;
continued inflationary pressures;
recession;
challenge by regulatory authorities of our claim to the ERC; and
risk factors contained in Item 1A of this report.

 

32
 

 


ITEM 8.
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

Index to Consolidated Financial Statements

 

Consolidated Financial Statements   Page No.
     
Report of Independent Registered Public Accounting Firm (PCAOB ID Number 248)   34
     
Consolidated Balance Sheets as of December 31, 2022 and 2021   36
     
Consolidated Statements of Operations for the years ended December 31, 2022 and 2021   38
     
Consolidated Statements of Comprehensive (Loss) Income for the years ended December 31, 2022 and 2021   39
     
Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2022 and 2021   40
     
Consolidated Statements of Cash Flows for the years ended December 31, 2022 and 2021   41
     
Notes to Consolidated Financial Statements   42

 

Financial Statement Schedules

 

In accordance with the rules of Regulation S-X, schedules are not submitted because they are not applicable to or required by the Company.

 

33
 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

Board of Directors and Stockholders

Perma-Fix Environmental Services, Inc.

 

Opinion on the financial statements

 

We have audited the accompanying consolidated balance sheets of Perma-Fix Environmental Services, Inc. (a Delaware corporation) and subsidiaries (the “Company”) as of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive (loss) income, stockholders’ equity, and cash flows for the years then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical audit matters

 

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

 

Revenue recognition for certain revenue contracts

 

As described further in note 2 to the financial statements, the Company has certain fixed price contracts that are long term in nature with non-standard terms. These terms and contract modifications impact revenue recognition and require significant effort and judgement by management. We have identified revenue recognition for these contracts as a critical audit matter.

 

The principal considerations for our determination that revenue recognition for these contracts is a critical audit matter are that there is a considerable auditor effort and judgement required to analyze and evaluate contracts for the types of terms and conditions that impact revenue recognition.

 

34
 

 

Our audit procedures related to the revenue recognition for these contracts included the following, among others.

  We obtained and inspected a selection of long-term, non-standard contracts and modifications and amendments to understand the terms and conditions and the related impact on revenue recognition, specifically the identification of:
    contract term,
    performance obligations, and
    determination of the measure of progress.
  We obtained the detail of underlying costs for each project and tested the underlying accuracy of the data by agreeing to supporting documentation.
  We utilized the cost data to recalculate management’s measure of completion for selected projects under the input method.
  We performed a retrospective review using contracts, which were tested through prior year procedures and completed during the current year, to evaluate management’s ability to accurately budget for input method contracts.
  We evaluated the appropriateness of the recording of revenue for both billed and unbilled amounts related to these contracts.

 

Realizability of deferred tax assets

 

As described further in note 14 to the financial statements, deferred tax assets are reduced by a valuation allowance if, based on the evaluation of positive and negative evidence, in management’s judgment it is more likely than not that some portion or all, of the deferred tax assets will not be realized. During the year ended December 31, 2022, management concluded that sufficient positive evidence exists to ensure the realizability of the US federal deferred tax assets.

 

The principal considerations for our determination that the realizability of US federal deferred tax assets is a critical audit matter are that the projected financial information related to the profitability of the Company which is reliant on the ability to predict future revenue is subject to significant management judgments in determining whether the net deferred tax assets are more likely than not to be realized in the future, which in turn led to a high degree of auditor judgement and effort in performing procedures and evaluating audit evidence related to management’s assessment of the realization of deferred tax assets.

 

Our audit procedures related to the realizability of US federal deferred tax assets included the following, among others.

  We evaluated the positive and negative evidence available to support management’s assessment of the realizability of the assets
  We tested the completeness and accuracy of the underlying data used in management’s assessment
  We evaluated the prospective financial information related to future profitability including consideration of:
    the current and past performance of the Company
    the consistency with external market and industry data
    the consistency with evidence obtained in other areas.

 

/s/GRANT THORNTON LLP

 

We have served as the Company’s auditor since 2014.

 

Atlanta, Georgia

March 23, 2023

 

35
 

 

PERMA-FIX ENVIRONMENTAL SERVICES, INC.

CONSOLIDATED BALANCE SHEETS

As of December 31,

 

   2022   2021 
(Amounts in Thousands, Except for Share and Per Share Amounts)  2022   2021 
         
ASSETS          
Current assets:          
Cash  $1,866   $4,440 
Accounts receivable, net of allowance for credit losses of $57 and $85, respectively   9,364    11,372 
Unbilled receivables   6,062    8,995 
Inventories   814    680 
Prepaid and other assets   5,405    4,472 
Current assets related to discontinued operations   15    15 
Total current assets   23,526    29,974 
           
Property and equipment:          
Buildings and land   24,021    20,631 
Equipment   21,242    22,131 
Vehicles   442    443 
Leasehold improvements   23    23 
Office furniture and equipment   1,299    1,316 
Construction-in-progress   727    2,997 
Total property and equipment   47,754    47,541 
Less accumulated depreciation   (28,797)   (28,932)
Net property and equipment   18,957    18,609 
           
Property and equipment related to discontinued operations   81    81 
           
Operating lease right-of-use assets   1,971    2,460 
           
Intangibles and other long term assets:          
Permits   9,610    9,476 
Other intangible assets - net   629    894 
Finite risk sinking fund (restricted cash)   11,570    11,471 
Deferred tax assets   4,116    3,527 
Other assets   438    809 
Total assets  $70,898   $77,301 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

36
 

 

PERMA-FIX ENVIRONMENTAL SERVICES, INC.

CONSOLIDATED BALANCE SHEETS, CONTINUED

As of December 31,

 

(Amounts in Thousands, Except for Share and per Share Amounts)  2022   2021 
         
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities:          
Accounts payable  $10,325   $11,975 
Accrued expenses   4,593    5,078 
Disposal/transportation accrual   887    1,065 
Deferred revenue   4,813    5,580 
Accrued closure costs - current   682    578 
Current portion of long-term debt   476    393 
Current portion of operating lease liabilities   416    406 
Current portion of finance lease liabilities   154    333 
Current liabilities related to discontinued operations   362    506 
Total current liabilities   22,708    25,914 
           
Accrued closure costs   7,284    6,613 
Long-term debt, less current portion   563    600 
Long-term operating lease liabilities, less current portion   1,584    2,029 
Long-term finance lease liabilities, less current portion   318    884 
Long-term liabilities related to discontinued operations   908    677 
Total long-term liabilities   10,657    10,803 
           
Total liabilities   33,365    36,717 
           
Commitments and Contingencies (Note 16)   -    - 
           
Stockholders’ Equity:          
           
Preferred Stock, $.001 par value; 2,000,000 shares authorized, no shares issued and outstanding        
Common Stock, $.001 par value; 30,000,000 shares authorized; 13,332,398 and 13,222,552 shares issued, respectively; 13,324,756 and 13,214,910 shares outstanding, respectively   13    13 
Additional paid-in capital   115,209    114,307 
Accumulated deficit   (77,436)   (73,620)
Accumulated other comprehensive loss   (165)   (28)
Less Common Stock in treasury, at cost; 7,642 shares   (88)   (88)
Total stockholders’ equity   37,533    40,584 
           
Total liabilities and stockholders’ equity  $70,898   $77,301 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

37
 

 

PERMA-FIX ENVIRONMENTAL SERVICES, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

For the years ended December 31,

 

    2022   2021 
(Amounts in Thousands, Except for Per Share Amounts)  2022   2021 
         
Net revenues  $70,599   $72,191 
Cost of goods sold   60,990    65,367 
Gross profit   9,609    6,824 
           
Selling, general and administrative expenses   14,652    12,845 
Research and development   336    746 
Loss on disposal of property and equipment   18    2 
Loss from operations   (5,397)   (6,769)
           
Other income (expense):          
Interest income   99    26 
Interest expense   (175)   (247)
Interest expense-financing fees   (61)   (41)
Other (Note 11)   1,945    (86)
Gain on extinguishment of debt (Note 11)       5,381 
Loss on deconsolidation of subsidiary (Note 15)       (1,062)
Loss from continuing operations before taxes   (3,589)   (2,798)
Income tax benefit   (378)   (3,890)
(Loss) income from continuing operations, net of taxes   (3,211)   1,092 
           
Loss from discontinued operations (Note 9)   (605)   (421)
Net (loss) income   (3,816)   671 
           
Net loss attributable to non-controlling interest       (164)
           
Net (loss) income attributable to Perma-Fix Environmental Services, Inc. common stockholders  $(3,816)  $835 
           
Net (loss) income per common share attributable to Perma-Fix Environmental Services, Inc. stockholders - basic and diluted:          
Continuing operations  $(.24)  $.10 
Discontinued operations   (.05)   (.03)
Net (loss) income per common share  $(.29)  $.07 
           
Number of common shares used in computing net (loss) income per share:          
Basic   13,280    12,433 
Diluted   13,280    12,673 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

38
 

 

PERMA-FIX ENVIRONMENTAL SERVICES, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

For the years ended December 31,

 

(Amounts in Thousands)  2022   2021 
(Amounts in Thousands)  2022   2021 
         
Net (loss) income  $(3,816)  $671 
Other comprehensive (loss) income:          
           
Foreign currency translation reclass to loss on deconsolidation of subsidiary (Note 15)       148 
Foreign currency translation adjustments   (137)   31 
Total other comprehensive (loss) income   (137)   179 
Comprehensive (loss) income   (3,953)   850 
Comprehensive loss attributable to non-controlling interest       (164)
Comprehensive (loss) income attributable to Perma-Fix Environmental Services, Inc. common stockholders  $(3,953)  $1,014 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

39
 

 

PERMA-FIX ENVIRONMENTAL SERVICES, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

For the years ended December 31,

(Amounts in Thousands, Except for Share Amounts)

 

   Shares   Amount   Capital   Treasury   Income   Subsidiary   Deficit   Equity 
   Common Stock   Additional
Paid-In
   Common Stock Held In   Accumulated
Other
Comprehensive
   Non-controlling
Interest in
   Accumulated   Total
Stockholders’
 
   Shares   Amount   Capital   Treasury   Income   Subsidiary   Deficit   Equity 
Balance at December 31, 2020   12,161,539   $12   $108,931   $(88)  $(207)  $(1,742)  $(74,455)  $32,451 
Net (loss) income                           (164)   835    671 
Foreign currency translation                   31            31 
Deconsolidation of subsidiary (Note 15)           (1,004)       148    1,906        1,050 
Issuance of Common Stock for services   60,723        427                    427 
Stock-Based Compensation           250                    250 
Issuance of Common Stock upon exercise of options   290                             
Sale of Common Stock, net of  offering costs (Note 7)   1,000,000    1    5,703                    5,704 
Balance at December 31, 2021   13,222,552   $13   $114,307   $(88)  $(28)  $    (73,620)  $40,584 
Net loss                           (3,816)   (3,816)
Foreign currency translation                   (137)           (137)
Issuance of Common Stock for services   90,920        481                    481 
Stock-Based Compensation           408                    408 
Issuance of Common Stock upon exercise of options   18,926        13                    13 
Balance at December 31, 2022   13,332,398   $13   $115,209   $(88)  $(165)  $   $(77,436)  $37,533 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

40
 

 

PERMA-FIX ENVIRONMENTAL SERVICES, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

For the years ended December 31,

 

(Amounts in Thousands)  2022   2021 
(Amounts in Thousands)  2022   2021 
Cash flows from operating activities:          
Net (loss) income  $(3,816)  $671 
Less: loss on discontinued operations (Note 9)   (605)   (421)
           
(Loss) income from continuing operations   (3,211)   1,092 
Adjustments to reconcile net (loss) income from continuing operations to cash provided by (used in) operating activities:          
Depreciation and amortization   2,109    1,687 
Interest on finance lease with purchase option       7 
Loss on deconsolidation of subsidiary (Note 15)       1,062 
Gain on extinguishment of debt (Note 11)       (5,381)
Amortization of debt issuance costs   60    40 
Deferred tax benefit   (390)   (3,860)
(Recovery of) provision for credit losses on accounts receivable   (20)   26 
Loss on disposal of property and equipment   18    2 
Issuance of common stock for services   481    427 
Stock-based compensation   408    250 
Changes in operating assets and liabilities of continuing operations:          
Accounts receivable   2,028    (1,739)
Unbilled receivables   2,933    5,458 
Prepaid expenses, inventories and other assets   2,018    1,165 
Accounts payable, accrued expenses and unearned revenue   (6,270)   (6,552)
Cash provided by (used in) provided by continuing operations   164    (6,316)
Cash used in discontinued operations   (717)   (521)
Cash used in operating activities   (553)   (6,837)
           
Cash flows from investing activities:          
Purchases of property and equipment (net)   (1,023)   (1,577)
Proceeds from sale of property and equipment   26    17 
Deconsolidation of subsidiary - cash       (4)
Cash used in investing activities of continuing operations   (997)   (1,564)
           
Cash flows from financing activities:          
Borrowing on revolving credit   73,322    74,987 
Repayments of revolving credit borrowings   (73,322)   (74,987)
Proceeds from capital line   524     
Principal repayment of finance lease liabilities   (860)   (334)
Principal repayments of long term debt   (502)   (440)
Payment of debt issuance costs   (35)   (48)
(Offering costs paid)/ proceeds from sale of Common Stock, net of offering costs paid (Note 7)   (61)   5,765 
Proceeds from issuance of Common Stock upon exercise of options   13     
Cash (used in) provided by financing activities of continuing operations   (921)   4,943 
           
Effect of exchange rate changes on cash   (4)   (1)
           
Decrease in cash and finite risk sinking fund (restricted cash) (Note 2)   (2,475)   (3,459)
Cash and finite risk sinking fund (restricted cash) at beginning of period (Note 2)   15,911    19,370 
Cash and finite risk sinking fund (restricted cash) at end of period (Note 2)  $13,436   $15,911 
           
Supplemental disclosure:          
Interest paid  $173   $230 
Income taxes paid   6    47 
Non-cash investing and financing activities:          
Equipment purchase subject to finance lease   114    556 
Equipment purchase subject to financing       29 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

41
 

 

PERMA-FIX ENVIRONMENTAL SERVICES, INC.

Notes to Consolidated Financial Statements

December 31, 2022 and 2021

 

NOTE 1 DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

 

Perma-Fix Environmental Services, Inc. (the Company, which may be referred to as we, us, or our), an environmental and technology know-how company, is a Delaware corporation, engaged through its subsidiaries, in three reportable segments:

 

TREATMENT SEGMENT, which includes:

 

- nuclear, low-level radioactive, mixed waste (containing both hazardous and low-level radioactive constituents), hazardous and non-hazardous waste treatment, processing and disposal services primarily through four uniquely licensed and permitted treatment and storage facilities; and
- R&D activities to identify, develop and implement innovative waste processing techniques for problematic waste streams.

 

SERVICES SEGMENT, which includes:

 

- Technical services, which include:

 

  professional radiological measurement and site survey of large government and commercial installations using advanced methods, technology and engineering;
  integrated Occupational Safety and Health services including IH assessments; hazardous materials surveys, e.g., exposure monitoring; lead and asbestos management/abatement oversight; indoor air quality evaluations; health risk and exposure assessments; health & safety plan/program development, compliance auditing and training services; and OSHA citation assistance;
  global technical services providing consulting, engineering, project management, waste management, environmental, and D&D field, technical, and management personnel and services to commercial and government customers; and
  on-site waste management services to commercial and governmental customers.

 

- Nuclear services, which include:

 

  technology-based services including engineering, D&D, specialty services and construction, logistics, transportation, processing and disposal;
  remediation of nuclear licensed and federal facilities and the remediation cleanup of nuclear legacy sites. Such services capability includes: project investigation; radiological engineering; partial and total plant D&D; facility decontamination, dismantling, demolition, and planning; site restoration; logistics; transportation; and emergency response; and

 

- A company owned equipment calibration and maintenance laboratory that services, maintains, calibrates, and sources (i.e., rental) health physics, IH and customized NEOSH instrumentation.

 

The Company’s continuing operations consist of the operations of our subsidiaries/facilities as follow: Diversified Scientific Services, Inc. (“DSSI”), Perma-Fix of Florida, Inc. (“PFF”), Perma-Fix of Northwest Richland, Inc. (“PFNWR”), Safety & Ecology Corporation (“SEC”), Perma-Fix Environmental Services UK Limited (“PF UK Limited”), Perma-Fix of Canada, Inc. (“PF Canada”) and Oak Ridge Environmental Waste Operations Center (“EWOC”).

 

The Company’s continuing operations also consisted of Perma-Fix ERRG, a variable interest entity (“VIE”) for which we were the primary beneficiary. The VIE was an unpopulated joint venture (“JV”) entered between the Company and Engineering/Remediation Resources Group, Inc. (“ERRG”) for a specific project under the Services Segment in which the Company and ERRG had a 51% and 49% partnership interest in the joint venture, respectively. During the fourth quarter of 2022, project work under the JV was completed As of December 31, 2022, total assets and liabilities under the VIE were each $0.

 

42
 

 

The Company’s discontinued operations (see “Note 9 – Discontinued Operations”) consist of operations of all our subsidiaries included in our Industrial Segment which encompasses subsidiaries divested in 2011 and prior and three previously closed locations.

 

For 2021, the Company’s segment also included the Medical Segment. The Medical Segment entailed the R&D of the Company’s medical isotope production technology by the Company’s majority-owned Polish subsidiary, Perma-Fix Medical S.A (“PFM Poland”), and PFM Poland’s wholly-owned subsidiary, Perma-Fix Medical Corporation (“PFMC”). The Company’s Medical Segment (or “PF Medical”) had not generated any revenue. During the fourth quarter of 2021, the Company made the strategic decision to cease all R&D activities under the Medical Segment which resulted in the sale of 100% of PFM Poland (See “Note 15 – PF Medical” for a discussion of this sale).

 

Financial Positions and Liquidity

 

The Company’s 2022 financial results continued to be impacted by COVID-19, among other things. The Company’s Treatment Segment began to see steady improvements in waste receipts starting in the second quarter of 2022 from certain customers who had previously delayed waste shipments due, in part, from the impact of COVID-19. This positive trend was negatively impacted by occurrences of severe weather conditions which resulted in temporary delays in waste shipments from certain customers and a temporary shortage in skilled production personnel which peaked through the fourth quarter of 2022 at one of the Company’s facilities. In early part of 2022, the Company’s Services Segment continued to experience delays/curtailments in project work by certain customers since the award of projects to us late in the second quarter of 2021 due to COVID-19 impact and/or administrative delays. However, starting in the second quarter of 2022, work under these projects had resumed/increased as the pandemic impacts began to subside and has since reached full operational status.

 

In 2022, the Company continued to realize delays in procurement and planning on behalf of our government clients that saw easing through the second half of the year. Heading into 2023, the Company expects to see continued improvements in waste receipts and continued increases in project work from contracts recently won and bids submitted in both segments that are awaiting awards, subject to potential impact of COVID-19 and economic impacts.

 

The Company’s cash flow requirements during the twelve months ended December 31, 2022 were primarily financed by its operations, cash on hand and credit facility availability. The Company’s cash flow requirements for the next twelve months will consist primarily of general working capital needs, scheduled principal payments on its debt obligations, remediation projects, and planned capital expenditures. The Company plans to fund these requirements from its operations, credit facility availability, cash on hand and a refund that it expects to receive under the Employee Retention Credit program under the CARES Act (see a discussion of this expected refund in “Note 11 – The Coronavirus Aid, Relief, and Economic Security Act (“CARES ACT) – Employee Retention Credit (“ERC”)”). The Company continues to explore all sources of increasing its capital and/or liquidity and to improve its revenue and working capital, including either amending our existing lines of credit, obtaining new term loans or entering into equity transactions. There are no assurances that we will be successful in increasing our liquidity though these efforts. The Company is continually reviewing operating costs and reviewing the possibility of further reducing operating costs and non-essential expenditures to bring them in line with revenue levels, when necessary. At this time, the Company believes that its cash flows from operations, available liquidity from its credit facility, cash on hand and the expected refund from the ERC program should be sufficient to fund its operations for the next twelve months. The Company continues to closely monitor any potential impact from the countries’ economic conditions and COVID-19 pandemic on all aspects of our business.

 

NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Principles of Consolidation

 

The Company’s consolidated financial statements include our accounts, those of our wholly-owned subsidiaries, and Perma-Fix ERRG, a VIE for which we were the primary beneficiary as discussed above, after elimination of all significant intercompany accounts and transactions. The consolidated financial statements for 2021 also included the accounts of the Company’s Medical Segment which was divested in December 2021 as discussed above.

 

43
 

 

Use of Estimates

 

The Company prepares financial statements in conformity with accounting standards generally accepted in the United States (“U.S. GAAP”), which may require estimates of future cash flows and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as, the reported amounts of revenues and expenses during the reporting period. Due to the inherent uncertainty involved in making estimates, actual results could differ from those estimates.

 

Cash and Finite Risk Sinking Fund (Restricted Cash)

 

At December 31, 2022, the Company had cash on hand of approximately $1,866,000. At December 31, 2021, the Company had cash on hand of approximately $4,440,000. At December 31, 2022 and 2021, the Company had finite risk sinking funds of approximately $11,570,000 and $11,471,000, respectively, which represented cash held as collateral under the Company’s financial assurance policy (see “Note 16 – Commitment and Contingencies – Insurance” for a discussion of this finite risk sinking fund).

 

Accounts Receivable

 

During the fourth quarter of 2022, the Company adopted ASU 2016-13, “Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments.” This ASU replaces the incurred loss impairment model with an expected credit loss impairment model for financial instruments, including accounts receivable. Accounts receivable are customer obligations due under normal trade terms requiring payment within 30 or 60 days from the invoice date based on the customer type (government, broker, or commercial). The new standard requires entities to consider forward-looking information to estimate expected credit losses, resulting in earlier recognition of losses for receivbles that are current or not yet due, which were not considered under the previous accounting guidance. In accordance with ASU 2016-13, the Company’s expected loss allowance methodology for receivables is developed using historical collection experience, current and future economic and market conditions that may affect customers’ ability to pay, and a review of the current status of customers’ accounts receivables. The Company does not apply a credit loss allowance to government related receivables due to our past successful experience in their collectability. The Company’s monitoring activities include routine follow-up on past due accounts and consideration of customers’ financial conditions. Once the Company has exhausted all options in the collection of a delinquent accounts receivable balance, which includes collection letters, demands for payment, collection agencies and attorneys, the account is deemed uncollectible and subsequently written off. The write off process involves approvals from senior management based on required approval thresholds.

 

The following table sets forth the activity in the allowance for credit losses for the years ended December 31, 2022 and 2021 (in thousands):

 

           
   Year Ended December 31, 
   2022   2021 
Allowance for credit losses - beginning of year  $85   $404 
(Recovery of) provision charges   (21)   41 
Write-off   (7)   (360)
Allowance for credit losses - end of year  $57   $85 

 

Unbilled Receivables

 

Unbilled receivables are generated by differences between invoicing timing and our over time revenue recognition methodology used for revenue recognition purposes. As major processing and contract completion phases are completed and the costs are incurred, the Company recognizes the corresponding percentage of revenue. Within our Treatment Segment, the facilities experience delays in processing invoices due to the complexity of the documentation that is required for invoicing, as well as the difference between completion of revenue recognition milestones and agreed upon invoicing terms, which results in unbilled receivables. The timing differences occur for several reasons which include: partially from delays in the final processing of all wastes associated with certain work orders and partially from delays for analytical testing that is required after the facilities have processed waste but prior to our release of waste for disposal. The tasks relating to these delays can take months to complete but are generally completed within twelve months.

 

44
 

 

Unbilled receivables within our Services Segment can result from work performed under contracts but invoice milestones have not yet been met and/or contract claims and pending change orders, including requests for equitable adjustments (“REA”) when work has been performed and collection of revenue is reasonably assured.

 

Inventories

 

Inventories consist of treatment chemicals, saleable used oils, and certain supplies. Additionally, the Company has replacement parts in inventory, which are deemed critical to the operating equipment and may also have extended lead times should the part fail and need to be replaced. Inventories are valued at the lower of cost or net realizable value with cost determined by the first-in, first-out method.

 

Disposal and Transportation Costs

 

The Company accrues for waste disposal based on the waste at each facility at the end of each accounting period. Current market prices for transportation and disposal costs are applied to the end of period waste inventories to calculate for the transportation and disposal accruals.

 

Property and Equipment

 

Property and equipment expenditures are capitalized and depreciated using the straight-line method over the estimated useful lives of the assets for financial statement purposes, while accelerated depreciation methods are principally used for income tax purposes. Generally, asset lives range from ten to forty years for buildings (including improvements and asset retirement costs) and three to seven years for office furniture and equipment, vehicles, and decontamination and processing equipment. Leasehold improvements are capitalized and amortized over the lesser of the term of the lease or the life of the asset. Maintenance and repairs are charged directly to expense as incurred. The cost and accumulated depreciation of assets sold or retired are removed from the respective accounts, and any gain or loss from sale or retirement is recognized in the accompanying Consolidated Statements of Operations. Renewals and improvements, which extend the useful lives of the assets, are capitalized.

 

Certain property and equipment expenditures are financed through leases. Amortization of financed leased assets is computed using the straight-line method over the estimated useful lives of the assets. At December 31, 2022, assets recorded under finance leases were $1,201,000 less accumulated depreciation of $549,000, resulting in net fixed assets under finance leases of $652,000. At December 31, 2021, assets recorded under finance leases were $2,409,000 less accumulated depreciation of $475,000, resulting in net fixed assets under finance leases of $1,934,000. These assets are recorded within net property and equipment on the Consolidated Balance Sheets.

 

Long-lived assets, such as property, plant and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are separately presented in the balance sheet and reported at the lower of the carrying amount or fair value less costs to sell, and are no longer depreciated.

 

Our depreciation expense totaled approximately $1,872,000 and $1,476,000 in 2022 and 2021, respectively.

 

Leases

 

The Company accounts for leases in accordance with FASB’s ASU 2016-02, “Leases (Topic 842).” At the inception of an arrangement, the Company determines if an arrangement is, or contains, a lease based on facts and circumstances present in that arrangement. Lease classifications, recognition, and measurement are then determined at the lease commencement date.

 

45
 

 

The Company’s operating lease right-of-use (“ROU”) assets and operating lease liabilities represent primarily leases for office and warehouse spaces used to conduct our business. These leases have remaining terms of approximately one to seven years which include additional options to renew. The Company includes renewal options in valuing its ROU assets and liabilities when it determines that it is reasonably certain to exercise these renewal options. As most of our operating leases do not provide an implicit rate, the Company uses its incremental borrowing rate as the discount rate when determining the present value of the lease payments. The incremental borrowing rate is determined based on the Company’s secured borrowing rate, lease terms and current economic environment. Some of our operating leases include both lease (rent payments) and non-lease components (maintenance costs such as cleaning and landscaping services). The Company has elected the practical expedient to account for lease component and non-lease component as a single component for all leases under ASU 2016-02. Lease expense for operating leases is recognized on a straight-line basis over the lease term.

 

Finance leases primarily consist of processing and transport equipment used by our facilities’ operations. The Company’s finance leases also included a building with land utilized for our waste treatment operations which included a purchase option. During the third quarter of 2021, the Company concluded that it was more likely than not that it would not exercise this purchase option but will continue to lease the property. Accordingly, a reassessment of this lease was performed which resulted in reclassification of this lease to an operating lease. The Company’s finance leases have remaining terms of approximately one to three years. See “Property and Equipment” above for assets recorded under financed leases. Borrowing rates for our finance leases are either explicitly stated in the lease agreements or implicitly determined from available terms in the lease agreements.

 

The Company adopted the policy to not recognize ROU assets and liabilities for short term leases.

 

Intangible Assets

 

Intangible assets consist primarily of the recognized value of the permits required to operate our business. Indefinite-lived intangible assets are not amortized but are reviewed for impairment annually as of October 1, or when events or changes in the business environment indicate that the carrying value may be impaired. If the fair value of the asset is less than the carrying amount, a quantitative test is performed to determine the fair value. The impairment loss, if any, is measured as the excess of the carrying value of the asset over its fair value. Judgments and estimates are inherent in these analyses and include assumptions for, among other factors, forecasted revenue, gross margin, growth rate, operating income, timing of expected future cash flows, and the determination of appropriate long-term discount rates. Impairment testing of our indefinite-lived permits related to our Treatment reporting unit as of October 1, 2022 and 2021 resulted in no impairment charges.

 

Intangible assets that have definite useful lives are amortized using the straight-line method over the estimated useful lives (with the exception of customer relationships which are amortized using an accelerated method) and are excluded from our annual intangible asset valuation review as of October 1. Definite-lived intangible assets are also tested for impairment whenever events or changes in circumstances suggest impairment might exist.

 

R&D

 

Operational innovation and technical know-how are very important to the success of our business. Our goal is to discover, develop, and bring to market innovative ways to process waste that address unmet environmental needs and to develop new company service offerings. The Company conducts research internally and also through collaborations with other third parties. R&D costs consist primarily of employee salaries and benefits, laboratory costs, third party fees, and other related costs associated with the development and enhancement of new potential waste treatment processes and new technology and are charged to expense when incurred in accordance with ASC Topic 730, “Research and Development.”

 

46
 

 

Accrued Closure Costs and ARO

 

Accrued closure costs represent our estimated environmental liability to clean up our facilities, as required by our permits, in the event of closure. ASC 410, “Asset Retirement and Environmental Obligations” requires that the discounted fair value of a liability for an ARO be recognized in the period in which it is incurred with the associated ARO capitalized as part of the carrying cost of the asset. The recognition of an ARO requires that management make numerous estimates, assumptions and judgments regarding such factors as estimated probabilities, timing of settlements, material and service costs, current technology, laws and regulations, and credit adjusted risk-free rate to be used. This estimate is inflated, using an inflation rate, to the expected time at which the closure will occur, and then discounted back, using a credit adjusted risk free rate, to the present value. ARO’s are included within buildings as part of property and equipment and are depreciated over the estimated useful life of the property. In periods subsequent to initial measurement of the ARO, the Company must recognize period-to-period changes in the liability resulting from the passage of time and revisions to either the timing or the amount of the original estimate of undiscounted cash flows. Increases in the ARO liability due to passage of time impact net income as accretion expense, which is included in cost of goods sold. Changes in costs resulting from changes or expansion at the facilities require adjustment to the ARO liability and are capitalized and charged as depreciation expense, in accordance with the Company’s depreciation policy.

 

Income Taxes

 

Income taxes are accounted for in accordance with ASC 740, “Income Taxes.” Under ASC 740, the provision for income taxes is comprised of taxes that are currently payable and deferred taxes that relate to the temporary differences between financial reporting carrying values and tax bases of assets and liabilities. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 requires that deferred income tax assets be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The Company regularly assesses the likelihood that the deferred tax asset will be recovered from future taxable income. The Company considers projected future taxable income and ongoing tax planning strategies, then records a valuation allowance to reduce the carrying value of the net deferred income taxes to an amount that is more likely than not to be realized.

 

ASC 740 sets out a consistent framework for preparers to use to determine the appropriate recognition and measurement of uncertain tax positions. ASC 740 uses a two-step approach wherein a tax benefit is recognized if a position is more-likely-than-not to be sustained. The amount of the benefit is then measured to be the highest tax benefit which is greater than 50% likely to be realized. ASC 740 also sets out disclosure requirements to enhance transparency of an entity’s tax reserves. The Company recognizes accrued interest and income tax penalties related to unrecognized tax benefits as a component of income tax expense.

 

The Company reassesses the validity of our conclusions regarding uncertain income tax positions on a quarterly basis to determine if facts or circumstances have arisen that might cause us to change our judgment regarding the likelihood of a tax position’s sustainability under audit.

 

Foreign Currency

 

The Company’s foreign subsidiaries include PF UK Limited and PF Canada and also included PF Medical. Assets and liabilities are translated to U.S. dollars at the exchange rate in effect at the balance sheet date and revenue and expenses at the average exchange rate for the period. Foreign currency translation adjustments for these subsidiaries are accumulated as a separate component of accumulated other comprehensive income (loss) in stockholders’ equity. Gains and losses resulting from foreign currency transactions are recognized in the Consolidated Statements of Operations.

 

Concentration Risk

 

The Company performed services relating to waste generated by government clients (domestic and foreign (primarily Canadian)), either indirectly for others as a subcontractor to government entities or directly as a prime contractor, representing approximately $60,030,000, or 85.0%, of our total revenue during 2022, as compared to $60,812,000, or 84.2%, of our total revenue during 2021.

 

47
 

 

Our revenues are project/event based where the completion of one contract with a specific customer may be replaced by another contract with a different customer from year to year.

 

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. The Company maintains cash with high quality financial institutions, which may exceed Federal Deposit Insurance Corporation (“FDIC”) insured amounts from time to time. Concentration of credit risk with respect to accounts receivable is limited due to the Company’s large number of customers and their dispersion throughout the United States as well as with the significant amount of work that we perform for government entities.

 

The Company had two government related customers whose total unbilled and net outstanding receivable balances represented 12.5% and 23.0% of the Company’s total consolidated unbilled and net accounts receivable at December 31, 2022. The Company had two government related customers whose total unbilled and net outstanding receivable balances represented 18.2% and 23.5% of the Company’s total consolidated unbilled and net accounts receivable at December 31, 2021.

 

Revenue Recognition and Related Policies

 

The Company recognizes revenue in accordance with FASB’s ASC 606, “Revenue from Contracts with Customers.” ASC 606 provides a single, comprehensive revenue recognition model for all contracts with customers. Under ASC 606, a five-step process is utilized in order to determine revenue recognition, depicting the transfer of goods or services to a customer at an amount that reflects the consideration it expects to receive in exchange for those goods or services. Under ASC 606, a performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account. A contract transaction price is allocated to each distinct performance obligation and recognized as revenues as the performance obligation is satisfied.

 

Treatment Segment Revenues:

 

Contracts in our Treatment Segment primarily have a single performance obligation as the promise to receive, treat and dispose of waste is not separately identifiable in the contract and, therefore, not distinct. Performance obligations are generally satisfied over time using the input method. Under the input method, the Company uses a measure of progress divided into major phases which include receipt (ranging from 9.0% to 33%), treatment/processing (ranging from 40% to 79%) and shipment/final disposal (ranging from 9.0% to 27%). As major processing phases are completed and the costs are incurred, the proportional percentage of revenue is recognized. Transaction price for Treatment Segment contracts are determined by the stated fixed rate per unit price as stipulated in the contract.

 

The Company periodically enter into arrangements with customers for transportation of wastes to either our facility or to non-company owned disposal sites. Revenue from this arrangement is recognized at a point in time, upon the transfer of control. Control transfers when the wastes are picked up by the Company.

 

Services Segment Revenues:

 

Revenues for our Services Segment are generated from time and materials or fixed price arrangements:

 

The Company’s primary obligation to customers in time and materials contracts relate to the provision of services to the customer at the direction of the customer. This provision of services at the request of the customer is the performance obligation, which is satisfied over time. Revenue earned from time and materials contracts is determined using the input method and is based on contractually defined billing rates applied to services performed and materials delivered.

 

Under fixed price contracts, the objective of the project is not attained unless all scope items within the contract are completed and all of the services promised within fixed fee contracts constitute a single performance obligation. Transaction price is estimated based upon the estimated cost to complete the overall project. Revenue from fixed price contracts is recognized over time primarily using the input method. For the input method, revenue is recognized based on costs incurred on the project relative to the total estimated costs of the project.

 

As discussed above for the Treatment and Services Segments, the Company’ revenue is generally recognized using the input method. This method of measuring progress provides a faithful depiction of the transfer to goods and services because the costs incurred are expected to be substantially proportionate to the Company’s satisfaction of the performance obligation.

 

48
 

 

Contracts with our customers within our Treatment Segment are generally short term with an original expected length of one year or less. For the Services Segment, contracts with our customers generally have original terms ranging from one year or less to approximately twenty-four months. The Company’s contracts and subcontracts relating to activities at governmental sites generally allow for termination for convenience at any time at the government’s option without payment of a substantial penalty.

 

Variable Consideration

 

The Company’s contracts generally do not give rise to variable consideration. However, from time to time, the Company may submit requests for equitable adjustments under certain of its government contracts for price or other modifications that are determined to be variable consideration. The Company estimates the amount of variable consideration to include in the estimated transaction price based on historical experience with government contracts, anticipated performance and management’s best judgment at the time and to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. These estimates are re-assessed each reporting period as required.

 

Significant Payment Terms

 

Invoicing is based on schedules established in customer contracts. Payment terms vary by customers but are generally established at 30 days from invoicing.

 

Incremental Costs to Obtain a Contract

 

Costs incurred to obtain contracts with our customers are immaterial and as a result, the Company expenses (within selling, general and administration expenses (“SG&A”)) incremental costs incurred in obtaining contracts with our customer as incurred.

 

Remaining Performance Obligations

 

The Company applies the practical expedient in ASC 606-10-50-14 and does not disclose information about remaining performance obligations that have original expected durations of one year or less.

 

Within our Services Segment, there are service contracts which provide that the Company has a right to consideration from a customer in an amount that corresponds directly with the value to the customer of our performance completed to date. For those contracts, the Company has utilized the practical expedient in ASC 606-10-55-18, which allows the Company to recognize revenue in the amount for which we have the right to invoice; accordingly, the Company does not disclose the value of remaining performance obligations for those contracts.

 

The Company’s contracts and subcontracts relating to activities at governmental sites generally allow for termination for convenience at any time at the government’s option without payment of a substantial penalty. The Company does not disclose remaining performance obligations on these contracts.

 

Stock-Based Compensation

 

Stock-based compensation granted to employees are accounted for in accordance with ASC 718, “Compensation – Stock Compensation.” Stock-based payment transactions for acquiring goods and services from nonemployees are also accounted for under ASC 718. ASC 718 requires stock-based payments to employees and nonemployees, including grant of options, to be recognized in the Statement of Operations based on their fair values. The Company uses the Black-Scholes option-pricing model to determine the fair-value of stock-based awards which requires subjective assumptions. Assumptions used to estimate the fair value of stock-based awards include the exercise price of the award, the expected term, the expected volatility of our stock over the stock-based award’s expected term, the risk-free interest rate over the award’s expected term, and the expected annual dividend yield. The Company accounts for forfeitures when they occur.

 

Comprehensive (Loss) Income